<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Acta Crystallogr D Struct Biol</journal-id><journal-id journal-id-type="iso-abbrev">Acta Crystallogr D Struct Biol</journal-id><journal-id journal-id-type="publisher-id">Acta Cryst. D</journal-id><journal-title-group><journal-title>Acta Crystallographica. Section D, Structural Biology</journal-title></journal-title-group><issn pub-type="epub">2059-7983</issn><publisher><publisher-name>International Union of Crystallography</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6778850</article-id><article-id pub-id-type="publisher-id">ag5031</article-id><article-id pub-id-type="doi">10.1107/S2059798319011938</article-id><article-id pub-id-type="coden">ACSDAD</article-id><article-id pub-id-type="pii">S2059798319011938</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Papers</subject></subj-group></article-categories><title-group><article-title>The flavin mononucleotide cofactor in &#x003b1;-hydroxyacid oxidases exerts its electrophilic/nucleophilic duality in control of the substrate-oxidation level</article-title><alt-title>Flavin mononucleotide cofactor in &#x003b1;-hydroxyacid oxidases</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Lyu</surname><given-names>Syue-Yi</given-names></name><xref ref-type="aff" rid="a">a</xref><xref ref-type="author-notes" rid="aunote1">&#x02021;</xref></contrib><contrib contrib-type="author"><name><surname>Lin</surname><given-names>Kuan-Hung</given-names></name><xref ref-type="aff" rid="a">a</xref><xref ref-type="aff" rid="b">b</xref><xref ref-type="author-notes" rid="aunote1">&#x02021;</xref></contrib><contrib contrib-type="author"><name><surname>Yeh</surname><given-names>Hsien-Wei</given-names></name><xref ref-type="aff" rid="a">a</xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Yi-Shan</given-names></name><xref ref-type="aff" rid="a">a</xref></contrib><contrib contrib-type="author"><name><surname>Huang</surname><given-names>Chun-Man</given-names></name><xref ref-type="aff" rid="a">a</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Yung-Lin</given-names></name><xref ref-type="aff" rid="a">a</xref></contrib><contrib contrib-type="author"><name><surname>Shih</surname><given-names>Hao-Wei</given-names></name><xref ref-type="aff" rid="a">a</xref></contrib><contrib contrib-type="author"><name><surname>Hsu</surname><given-names>Ning-Shian</given-names></name><xref ref-type="aff" rid="a">a</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-5079-5839</contrib-id><name><surname>Wu</surname><given-names>Chang-Jer</given-names></name><xref ref-type="aff" rid="c">c</xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Tsung-Lin</given-names></name><xref ref-type="aff" rid="a">a</xref><xref ref-type="aff" rid="d">d</xref><xref ref-type="corresp" rid="cor">*</xref></contrib><aff id="a">
<label>a</label>Genomics Research Center, <institution>Academia Sinica</institution>, Taipei 115, <country>Taiwan</country>
</aff><aff id="b">
<label>b</label>Institute of Biochemistry and Molecular Biology, <institution>National Yang-Ming University</institution>, Taipei 112, <country>Taiwan</country>
</aff><aff id="c">
<label>c</label>Department of Food Science, <institution>National Taiwan Ocean University</institution>, Keelung 202, <country>Taiwan</country>
</aff><aff id="d">
<label>d</label>Biotechnology Center, <institution>National Chung Hsing University</institution>, Taichung City 402, <country>Taiwan</country>
</aff></contrib-group><author-notes><corresp id="cor">Correspondence e-mail: <email>tlli@gate.sinica.edu.tw</email></corresp><fn id="aunote1"><label>&#x02021;</label><p>These authors contributed equally to this work.</p></fn></author-notes><pub-date pub-type="collection"><day>01</day><month>10</month><year>2019</year></pub-date><pub-date pub-type="epub"><day>24</day><month>9</month><year>2019</year></pub-date><pub-date pub-type="pmc-release"><day>24</day><month>9</month><year>2019</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. --><volume>75</volume><issue>Pt 10</issue><issue-id pub-id-type="publisher-id">d191000</issue-id><fpage>918</fpage><lpage>929</lpage><history><date date-type="received"><day>02</day><month>4</month><year>2019</year></date><date date-type="accepted"><day>28</day><month>8</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; Lyu et al. 2019</copyright-statement><copyright-year>2019</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original authors and source are cited.</license-p><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">http://creativecommons.org/licenses/by/4.0/</ali:license_ref></license></permissions><self-uri xlink:href="https://doi.org/10.1107/S2059798319011938">A full version of this article is available from Crystallography Journals Online.</self-uri><abstract abstract-type="toc"><p>Structural and enzymological explorations of <italic>p</italic>-hydroxy-mandelate oxidase and its mutants uncover an unprecedented electrophilic/nucleophilic duality for the flavin mononucleotide cofactor as well as an intramolecular disproportionation mechanism for an oxidative decarboxylation reaction.</p></abstract><abstract><p>The Y128F single mutant of <italic>p</italic>-hydroxymandelate oxidase (Hmo) is capable of oxidizing mandelate to benzoate via a four-electron oxidative decarboxylation reaction. When benzoylformate (the product of the first two-electron oxidation) and hydrogen peroxide (an oxidant) were used as substrates the reaction did not proceed, suggesting that free hydrogen peroxide is not the committed oxidant in the second two-electron oxidation. How the flavin mononucleotide (FMN)-dependent four-electron oxidation reaction takes place remains elusive. Structural and biochemical explorations have shed new light on this issue. 15 high-resolution crystal structures of Hmo and its mutants liganded with or without a substrate reveal that oxidized FMN (FMN<sub>ox</sub>) possesses a previously unknown electrophilic/nucleophilic duality. In the Y128F mutant the active-site perturbation ensemble facilitates the polarization of FMN<sub>ox</sub> to a nucleophilic ylide, which is in a position to act on an &#x003b1;-ketoacid, forming an N5-acyl-FMN<sub>red</sub> dead-end adduct. In four-electron oxidation, an intramolecular disproportion&#x000ad;ation reaction via an N5-alkanol-FMN<sub>red</sub> C&#x02032;&#x003b1; carbanion intermediate may account for the ThDP/PLP/NADPH-independent oxidative decarboxylation reaction. A synthetic 5-deaza-FMN<sub>ox</sub> cofactor in combination with an &#x003b1;-hydroxyamide or &#x003b1;-ketoamide biochemically and structurally supports the proposed mechanism.</p></abstract><kwd-group><kwd>electrophilic/nucleophilic duality</kwd><kwd>&#x003b1;-hydroxyacid oxidases</kwd><kwd>flavin mononucleotide</kwd><kwd>oxidative decarboxylation</kwd><kwd>monooxygenase</kwd><kwd><italic>p</italic>-hydroxymandelate oxidase</kwd></kwd-group><funding-group><award-group><funding-source>Ministry of Science and Technology, Taiwan</funding-source><award-id>102-2311-B-001-028-MY3</award-id><award-id>105-2311-B-001-050</award-id><award-id>106-2113-M-001-013-MY2</award-id></award-group><award-group><funding-source>Academia Sinica</funding-source></award-group><funding-statement>This work was funded by <funding-source>Ministry of Science and Technology, Taiwan</funding-source> grants <award-id>102-2311-B-001-028-MY3</award-id>, <award-id>105-2311-B-001-050</award-id>, and <award-id>106-2113-M-001-013-MY2</award-id>. <funding-source>Academia Sinica</funding-source> grant . </funding-statement></funding-group><counts><page-count count="12"/></counts></article-meta></front><body><sec sec-type="introduction" id="sec1"><label>1.</label><title>Introduction &#x000a0; </title><p>
<italic>p</italic>-Hydroxymandelate oxidase (Hmo) is a flavin mononucleotide (FMN)-dependent enzyme that oxidizes mandelate to benzoylformate. Its Y128F single mutant unexpectedly shows a new reactivity and is able to oxidize mandelate to benzoate via benzoylformate, a four-electron oxidation reaction that is typically catalysed by a monooxygenase. However, when using benzoylformate in place of mandelate the reaction becomes stuck in the absence or the presence of hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>; Yeh <italic>et al.</italic>, 2019<xref ref-type="bibr" rid="bb39"> &#x025b8;</xref>; Fig.&#x000a0;1<xref ref-type="fig" rid="fig1"> &#x025b8;</xref>). To the best of our knowledge, this is the second example after lactate monooxygenase (LMO) of an enzyme that performs a ThDP/PLP/NADPH-independent oxidative decarboxylation reaction at the expense of one molecule of O<sub>2</sub> with the concomitant production of CO<sub>2</sub> and H<sub>2</sub>O (Ghisla &#x00026; Massey, 1989<xref ref-type="bibr" rid="bb13"> &#x025b8;</xref>). It has been hypothesized that the H<sub>2</sub>O<sub>2</sub> generated at the active site of LMO acts on pyruvate to form acetate by H<sub>2</sub>O<sub>2</sub>-mediated oxidative decarboxylation because the dissociation of pyruvate is a slow step (Giegel <italic>et al.</italic>, 1990<xref ref-type="bibr" rid="bb15"> &#x025b8;</xref>; Lopalco <italic>et al.</italic>, 2016<xref ref-type="bibr" rid="bb20"> &#x025b8;</xref>). Aside from this non-ping-pong kinetic description, how H<sub>2</sub>O<sub>2</sub> mediates the oxidative decarboxylation of an &#x003b1;-ketoacid at the molecular level remains elusive (Choong &#x00026; Massey, 1980<xref ref-type="bibr" rid="bb7"> &#x025b8;</xref>; Ghisla &#x00026; Massey, 1977<xref ref-type="bibr" rid="bb12"> &#x025b8;</xref>; Lockridge <italic>et al.</italic>, 1972<xref ref-type="bibr" rid="bb19"> &#x025b8;</xref>; Walsh <italic>et al.</italic>, 1973<xref ref-type="bibr" rid="bb34"> &#x025b8;</xref>). It has been noted that the electron reactivity of FMN in flavin-dependent enzymes is the main factor governing the implementation of a given type of reaction by the dioxygen, substrates and enzyme&#x02013;cofactor system. C4&#x003b1; and N5 of the isoalloxazine ring of FMN are the most reactive centers, electrophilically or nucleophilically interacting with a substrate through a covalent linkage or spatiotemporally conveying electrons during redox reactions (Walsh &#x00026; Wencewicz, 2013<xref ref-type="bibr" rid="bb36"> &#x025b8;</xref>). In a previous study (Yeh <italic>et al.</italic>, 2019<xref ref-type="bibr" rid="bb39"> &#x025b8;</xref>), benzoylformate was found to be able to adopt a <italic>pro-R</italic> orientation with reference to the <italic>si</italic> face of the iso&#x000ad;alloxazine ring. This structural re&#x000ad;orientation aligns the nucleophilic N5 or C4&#x003b1;-OOH of reduced FMN (FMN<sub>red</sub>) with an appropriate trajectory to the electrophilic &#x003b1;-keto carbon of the &#x003b1;-ketoacid, a reaction reminiscent of the suicide inhibition of monoamine oxidase by mofegiline by forming an inactive N5 adduct or the formation of indole-3-acetate in auxin biosynthesis by the NADPH flavin-dependent monooxygenase YUC via a C4&#x003b1;-OOH decarboxylation-assisted mechanism (Wu <italic>et al.</italic>, 2005<xref ref-type="bibr" rid="bb38"> &#x025b8;</xref>; Stepanova <italic>et al.</italic>, 2011<xref ref-type="bibr" rid="bb27"> &#x025b8;</xref>; Milczek <italic>et al.</italic>, 2008<xref ref-type="bibr" rid="bb23"> &#x025b8;</xref>; Dai <italic>et al.</italic>, 2013<xref ref-type="bibr" rid="bb8"> &#x025b8;</xref>). In this report, both biochemical and structural measures were exploited in an attempt to address how a single O atom dictates the oxidation level in the reactions catalyzed by wild-type Hmo and its Y128F mutant.</p></sec><sec sec-type="materials|methods" id="sec2"><label>2.</label><title>Materials and methods &#x000a0; </title><sec id="sec2.1"><label>2.1.</label><title>Cloning and protein purification &#x000a0; </title><p>The <italic>hmo</italic> gene (<italic>orf22</italic>) was amplified from <italic>Amycolatopsis orientalis</italic> genomic DNA by polymerase chain reaction and was subcloned into the expression vector pET-28a(+) to generate the protein with an N-terminal His<sub>6</sub> tag. The expression plasmid was transformed into <italic>Escherichia coli</italic> BL21(DE3) cells by electroporation and the cells were grown on LB agar plates containing 50&#x02005;&#x000b5;g&#x02005;ml<sup>&#x02212;1</sup> kanamycin for 16&#x02005;h at 37&#x000b0;C. A single colony was grown overnight in 5&#x02005;ml LB medium containing 50&#x02005;&#x000b5;g&#x02005;ml<sup>&#x02212;1</sup> kanamycin at 37&#x000b0;C. The cell culture was used to inoculate 1&#x02005;l LB medium containing 50&#x02005;&#x000b5;g&#x02005;l<sup>&#x02212;1</sup> kanamycin. For protein expression and purification, the transformed <italic>E. coli</italic> cells were cultured, induced with 200&#x02005;&#x000b5;l 1.0&#x02005;<italic>M</italic> IPTG at an OD<sub>600</sub> of 0.6 and grown for a further 24&#x02005;h at 16&#x000b0;C. The cells were harvested by centrifugation, resuspended in 20&#x02005;ml binding buffer (20&#x02005;m<italic>M</italic> HEPES pH 7.5, 500&#x02005;m<italic>M</italic> NaCl, 10&#x02005;m<italic>M</italic> imidazole, 10% glycerol) and lysed using a microfluidizer or by sonication. The supernatant of the lysate after centrifugation at 16&#x02005;000&#x02005;rev&#x02005;min<sup>&#x02212;1</sup> for 30&#x02005;min was applied onto an Ni<sup>2+</sup>&#x02013;NTA resin column. The bound protein was sequentially washed with 10&#x02005;ml binding buffer (50&#x02005;m<italic>M</italic> HEPES pH 8, 200&#x02005;m<italic>M</italic> NaCl, 20&#x02005;m<italic>M</italic> imidazole) and 10&#x02005;ml wash buffer (50&#x02005;m<italic>M</italic> HEPES pH 8, 200&#x02005;m<italic>M</italic> NaCl, 80&#x02005;m<italic>M</italic> imidazole) before elution with 10&#x02005;ml elution buffer (20&#x02005;m<italic>M</italic> HEPES pH 8, 500&#x02005;m<italic>M</italic> NaCl, 250&#x02005;m<italic>M</italic> imidazole). Gel filtration was performed using an &#x000c4;KTA FPLC system equipped with a HiLoad 16/60 Superdex 200 column (Amersham Bioscience) under isocratic conditions (20&#x02005;m<italic>M</italic> HEPES pH 8, 100&#x02005;m<italic>M</italic> NaCl).</p></sec><sec id="sec2.2"><label>2.2.</label><title>Crystallization and data collection &#x000a0; </title><p>The purified proteins were crystallized using the hanging-drop vapor-diffusion method. Hmo and its Y128F, Y128C and R163L mutants were concentrated to 7&#x02005;mg&#x02005;ml<sup>&#x02212;1</sup> in 50&#x02005;m<italic>M</italic> HEPES pH 8.0 buffer solution and crystallized using a solution consisting of 35% Tascimate, 0.1&#x02005;<italic>M</italic> bis-Tris propane pH 7.0 in a 50:50 volume ratio. Crystals appeared within five days in VDX48 plates (Hampton Research) with sealant at 20&#x000b0;C. For Hmo and its mutants in complex with (<italic>S</italic>)-mandelate (SMA), benzoylformate (BF), benzoic acid (BA), phenyl&#x000ad;pyruvate (PPY), oxaloacetate (OAA) or mandelamide (MAAD), each crystal was soaked with 10&#x02013;30&#x02005;m<italic>M</italic> of the designated ligand dissolved in the mother solution for between 10&#x02005;min and 24&#x02005;h before data collection. All crystals were transferred to a solution containing cryoprotectants and flash-cooled in liquid nitrogen prior to data collection. The cryoprotectant-containing solution for Hmo and the Y128F mutant consisted of 20%(<italic>w</italic>/<italic>v</italic>) glycerol and 35% Tascimate. X-ray diffraction data were recorded at an operating temperature of 100&#x02005;K using an ADSC Quantum 315 or an MX300HE CCD detector on beamlines 13B1, 13C1, 15A1 or 05A at the National Synchrotron Radiation Research Center, Taiwan or beamline 44XU at SPring-8, Japan. All of the crystals belonged to the same space group: <italic>I</italic>422.</p></sec><sec id="sec2.3"><label>2.3.</label><title>Structure determination and refinement &#x000a0; </title><p>Data were indexed and scaled using the <italic>HKL</italic>-2000 package (Otwinowski &#x00026; Minor, 1997<xref ref-type="bibr" rid="bb25"> &#x025b8;</xref>). The crystal structures were determined by the molecular-replacement (MR) method using <italic>Phaser-MR</italic> from the <italic>CCP</italic>4 suite (McCoy <italic>et al.</italic>, 2007<xref ref-type="bibr" rid="bb22"> &#x025b8;</xref>; Winn <italic>et al.</italic>, 2011<xref ref-type="bibr" rid="bb40"> &#x025b8;</xref>). The crystal structure of hydroxyacid oxidase (PDB entry <ext-link ext-link-type="uri" xlink:href="https://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&#x00026;pdbId=3sgz">3sgz</ext-link>; Chen <italic>et al.</italic>, 2012<xref ref-type="bibr" rid="bb41"> &#x025b8;</xref>) was used as the search model for solving the initial phase. The polypeptide structures were built and refined using <italic>REFMAC</italic> (Murshudov <italic>et al.</italic>, 2011<xref ref-type="bibr" rid="bb50"> &#x025b8;</xref>). Subsequent iterative cycles of model building and refinement were performed using <italic>Coot</italic> (Emsley <italic>et al.</italic>, 2010<xref ref-type="bibr" rid="bb10"> &#x025b8;</xref>) and <italic>PHENIX</italic> (Afonine <italic>et al.</italic>, 2012<xref ref-type="bibr" rid="bb1"> &#x025b8;</xref>). All non-H atoms were refined with anisotropic displacement parameters. Both protein structures and electron-density maps were generated using <italic>PyMOL</italic> (DeLano, 2002<xref ref-type="bibr" rid="bb9"> &#x025b8;</xref>). Detailed refinement statistics are presented in Table 1<xref ref-type="table" rid="table1"> &#x025b8;</xref>.</p></sec><sec id="sec2.4"><label>2.4.</label><title>Site-directed mutagenesis &#x000a0; </title><p>The site-directed Hmo point mutants Y128C, Y128F and R163L were generated using QuikChange (Stratagene). The primers for mutant preparation are listed in <ext-link ext-link-type="uri" xlink:href="#suppinfoanchor">Supplementary Table S1</ext-link>. The mutations were confirmed by DNA sequencing. Each mutated protein was purified using the same protocol as used for wild-type Hmo.</p></sec><sec id="sec2.5"><label>2.5.</label><title>Chemoenzymatic synthesis of 5-deazaflavin mononucleotide &#x000a0; </title><p>To obtain 5-deazaflavin mononucleotide, the commercially available compounds 3,4-dimethylaniline, sodium cyanoboro&#x000ad;hydride and <sc>d</sc>-ribose were used as starting materials, following the synthetic procedure described in <ext-link ext-link-type="uri" xlink:href="#suppinfoanchor">Supplementary Scheme S1</ext-link>. Chemically synthesized deazariboflavin was purified using column chromatography, characterized by mass spectrometry or NMR and converted to catalytically active 5-deaza-FMN by riboflavin kinase. The gene coding for riboflavin kinase was amplified from the genomic DNA of <italic>E.&#x000a0;coli</italic> K12 and was subcloned into a pET-28a vector to carry an N-terminal His<sub>6</sub> tag. The constructed plasmid was then transformed into <italic>E. coli</italic> BL21(DE3) cells for overexpression. The overexpressed protein was purified using Ni<sup>2+</sup>&#x02013;NTA affinity chromatography and concentrated to 15&#x02005;mg&#x02005;ml<sup>&#x02212;1</sup>. The reaction was initiated by the addition of 2&#x02005;mg&#x02005;ml<sup>&#x02212;1</sup> riboflavin kinase to a reaction solution consisting of HEPES pH 7.5 with 5&#x02005;m<italic>M</italic> ATP, 5&#x02005;m<italic>M</italic> MgSO<sub>4</sub> and 10&#x02005;m<italic>M</italic> 5-deazariboflavin overnight. The sample solution was purified by HPLC and confirmed by mass spectrometry.</p></sec><sec id="sec2.6"><label>2.6.</label><title>Preparation of 5-deaza-FMN-containing Hmo and its Y128F mutant &#x000a0; </title><p>The deflavination and reconstitution of Hmo and its Y128F mutant were performed on an Ni<sup>2+</sup>&#x02013;NTA resin column by circulating a solution of HEPES buffer containing 10&#x02005;m<italic>M</italic> deazariboflavin (Hefti <italic>et al.</italic>, 2003<xref ref-type="bibr" rid="bb16"> &#x025b8;</xref>). The Ni<sup>2+</sup>&#x02013;NTA resin column was loaded and saturated with a solution of the target protein at a flow rate of 0.2&#x02005;ml&#x02005;min<sup>&#x02212;1</sup> using a peristaltic pump, which was installed between the sample reservoir and the column, to ensure maximal binding. Ten volumes of denaturing buffer (50&#x02005;m<italic>M</italic> HEPES, 2&#x02005;<italic>M</italic> potassium bromide, 2&#x02005;<italic>M</italic> urea pH 8.0) were subsequently used to unfold Hmo or its Y128F mutant, allowing removal of the FMN prosthetic cofactor from Hmo or its Y128F mutant. On-column replacement with 5-deaza-FMN was completed by circulating a buffer solution consisting of 50&#x02005;m<italic>M</italic> HEPES pH 8.0, 10&#x02005;m<italic>M</italic> 5-deaza-FMN at 0.2&#x02005;ml&#x02005;min<sup>&#x02212;1</sup> overnight. Hmo or its Y128F mutant containing 5-deaza-FMN was eluted using 10&#x02005;ml elution buffer (20&#x02005;m<italic>M</italic> HEPES pH 8, 200&#x02005;m<italic>M</italic> NaCl, 250&#x02005;m<italic>M</italic> imidazole). An analytical gel-filtration experiment using a Superdex 200 16/20 column confirmed that 5-deaza-FMN-containing Hmo (5-deaza-Hmo) and its Y128F mutant have an unchanged tetrameric state after the refolding process. The purified enzymes were concentrated to 10&#x02005;mg&#x02005;ml<sup>&#x02212;1</sup> for enzymatic assays and protein crystallization.</p></sec><sec id="sec2.7"><label>2.7.</label><title>Enzymatic assays using 5-deaza-Hmo and its Y128F mutant &#x000a0; </title><p>A typical enzymatic reaction (10&#x02005;&#x000b5;g 5-deaza-Hmo or its Y128F mutant) was carried out in 200&#x02005;&#x000b5;l buffer solution (20&#x02005;m<italic>M</italic> HEPES, 100&#x02005;m<italic>M</italic> NaCl pH 7.5, 5&#x02005;m<italic>M</italic>
<italic>S</italic>-mandelate, benzoylformate or benzoic acid) at 25&#x000b0;C for 2&#x02005;h. Reactions were quenched using 6&#x02005;<italic>N</italic> HCl and subjected to HPLC-MS analysis (using an Agilent 1260 Infinity Quaternary LC module connected to a Thermo-Finnigan LTQ-XL). Analytes were separated using a reverse-phase C<sub>18</sub> column (4.6 &#x000d7; 250&#x02005;mm, 5&#x02005;&#x000b5;m, C<sub>18</sub> Prodigy, Phenomenex) at a flow rate of 1&#x02005;ml&#x02005;min<sup>&#x02212;1</sup> in a mobile system programmed as a linear gradient from 2% to 40% solvent <italic>B</italic> against solvent <italic>A</italic> over 25&#x02005;min followed by 98% solvent <italic>B</italic> for a further 8&#x02005;min (solvent <italic>A</italic>, water with 1% formic acid; solvent <italic>B</italic>, acetonitrile with 1% formic acid). The data were recorded using a UV detector with the wavelength set to 254/280&#x02005;nm and the mass spectrometer in positive mode.</p></sec><sec id="sec2.8"><label>2.8.</label><title>UV&#x02013;Vis absorption measurements of reactions of Hmo and its Y128F mutant &#x000a0; </title><p>Ultraviolet and visible absorption spectra were recorded using a Beckman spectrophotometer (DU-800). In aqueous solution, freshly prepared Hmo or its Y128F mutant (0.125&#x02005;m<italic>M</italic> in 0.05&#x02005;<italic>M</italic> HEPES, 0.1&#x02005;<italic>M</italic> NaCl pH 7.5) were mixed with substrates (2.5&#x02013;5&#x02005;m<italic>M</italic>) and incubated in a quartz cuvette at ambient temperature for 2&#x02005;h. The absorption spectra of the reactions were recorded from 300 to 600&#x02005;nm. For the redissolved crystals/crystalloids, more than 100 crystals of Hmo or its Y128F mutant (after soaking with substrates at 5&#x02005;m<italic>M</italic> for 2&#x02005;h) were picked from hanging-drop crystallization plates and redissolved in the mother liquor in a UV quartz cuvette before spectral scanning.</p></sec></sec><sec sec-type="discussion|interpretation" id="sec3"><label>3.</label><title>Results and discussion &#x000a0; </title><sec id="sec3.1"><label>3.1.</label><title>Inhibition of &#x003b1;-ketoacids &#x000a0; </title><p>To investigate the mechanism of the four-electron oxidative decarboxylation reaction catalyzed by the Hmo single mutant Y128F, we first solved crystal structures of the Y128F mutant in complex with different ligands such as (<italic>S</italic>)-mandelate, (<italic>S</italic>)-2-phenylpropionate, benzoylformate, benzaldehyde and benzoate. The ternary complexes of Hmo and its Y128F mutant were then compared, whereupon it was observed that the superpositioned complexes showed no apparent structural variations between Hmo and the Y128F mutant (r.m.s.d. of &#x0003c;0.1&#x02005;&#x000c5;; <ext-link ext-link-type="uri" xlink:href="#suppinfoanchor">Supplementary Fig. S2</ext-link>) in terms of chemical conformations and spatial positions of both the proteins and ligands. When the crystals were soaked with benzoylformate, the formation of an N5-benzoyl-FMN adduct with an N5&#x02013;C&#x02032;&#x003b1; linkage was observed [Fig. 2<xref ref-type="fig" rid="fig2"> &#x025b8;</xref>(<italic>a</italic>)]. MS analysis confirmed that the benzoyl moiety was covalently linked to FMN [Fig. 2<xref ref-type="fig" rid="fig2"> &#x025b8;</xref>(<italic>b</italic>)]. When the crystals were soaked with benzaldehyde, the formation of a covalent adduct was not observed. This outcome suggests that the &#x003b1;-ketoacid moiety is a prerequisite for the formation of the covalent adduct, in which the decarboxylation of the terminal carboxyl group of the &#x003b1;-ketoacid is likely to take place after the formation of the N5&#x02013;C&#x02032;&#x003b1; linkage. Moreover, when the crystals of the Y128F mutant were soaked with (<italic>S</italic>)-3-phenyllactate, phenylpyruvate or phenylacetate [Fig. 2<xref ref-type="fig" rid="fig2"> &#x025b8;</xref>(<italic>a</italic>)], we observed that (<italic>S</italic>)-3-phenyllactate was oxidized to phenylacetate (a four-electron oxidative decarboxylation), phenylpyruvate ended up as an N5-phenylacetyl-FMN adduct and phenylacetate stayed as it was. When the crystals were soaked with oxaloacetate, an N5-malonyl-FMN adduct was found [Fig. 2<xref ref-type="fig" rid="fig2"> &#x025b8;</xref>(<italic>a</italic>)], leading overall to the conclusion that the formation of the covalent N5 adducts is &#x003b1;-ketoacid-dependent.</p><p>In most flavin-dependent oxidoreductases the FMN<sub>ox</sub> cofactor acts as an electron sink (electrophile) that accepts electrons or hydrides conveyed from a substrate or NADH/NADPH in the reductive half-reaction. The nitroalkane oxidase from the fungus <italic>Fusarium oxysporum</italic> and the alkyldihydroxyacetone phosphate synthase in human fibroblasts are two rare cases in which a carbanion is generated at the active site prior to addition to N5 of the flavin cofactor as a covalent adduct (Razeto <italic>et al.</italic>, 2007<xref ref-type="bibr" rid="bb26"> &#x025b8;</xref>; Heroux <italic>et al.</italic>, 2009<xref ref-type="bibr" rid="bb17"> &#x025b8;</xref>). However, a question arises in the context of how two electrophiles (FMN<sub>ox</sub> and &#x003b1;-ketoacid) are covalently associated in the Y128F mutant. One likelihood is that the &#x003b1;-ketoacid undergoes decarboxylation in the first instance to form a localized C&#x02032;&#x003b1; carbanion that then acts on FMN<sub>ox</sub>, but an &#x003b1;-ketoacid that spontaneously undergoes decarboxylation is chemically untenable. The second possibility is that the <italic>sp</italic>
<sup>2</sup> N5 atom of FMN<sub>ox</sub> acts as a nucleophile, but this scenario likewise contradicts the current understanding: FMN<sub>ox</sub> is a strong electrophile that accepts electrons. Nevertheless, an extra chunk of electron density at the top of N5 of FMN<sub>ox</sub> was observed in unbiased difference electron-density maps, and this electron density was denser in the Y128F mutant than in the wild type [Figs. 2<xref ref-type="fig" rid="fig2"> &#x025b8;</xref>(<italic>c</italic>) and 2<xref ref-type="fig" rid="fig2"> &#x025b8;</xref>(<italic>d</italic>)]. This additional electron density suggests that the C4&#x003b1;=N5 double bond in FMN<sub>ox</sub> is polarized to a C4&#x003b1;<sup>+</sup>&#x02013;N5<sup>&#x02212;</sup> ylide (a tertiary carbocation and a tetrahedral <italic>sp</italic>
<sup>3</sup> amine anion), as manifested by uneven wedge-shaped electron density for the &#x003c0;-bond [Figs. 2<xref ref-type="fig" rid="fig2"> &#x025b8;</xref>(<italic>c</italic>), 2<xref ref-type="fig" rid="fig2"> &#x025b8;</xref>(<italic>d</italic>), 3<xref ref-type="fig" rid="fig3"> &#x025b8;</xref>(<italic>a</italic>) and 3<xref ref-type="fig" rid="fig3"> &#x025b8;</xref>(<italic>b</italic>)]. The extent of polarization appears to be a function of an active-site perturbation ensemble (<italic>e.g.</italic> the point mutation), reflecting cooperative interplay of the hydrogen-bond network between water, FMN and active-site residues as well as ligands [Figs. 3<xref ref-type="fig" rid="fig3"> &#x025b8;</xref>(<italic>c</italic>) and 3<xref ref-type="fig" rid="fig3"> &#x025b8;</xref>(<italic>d</italic>)]. The formation of the adduct is thereby proposed to take place as follows: the <italic>sp</italic>
<sup>3</sup> N5 atom of the polarized FMN<sub>ox</sub> attacks the carbonyl C atom of the &#x003b1;-ketoacid to form a covalent C&#x02032;&#x003b1;&#x02013;N5 adduct, whereupon decarboxylation takes place, resulting in a localized C&#x02032;&#x003b1; carbanion. The lone pair of the C&#x02032;&#x003b1; carbanion subsequently hybridizes with the &#x003c0; orbital of N5 to reinstate the neutrality of C4&#x003b1;. Upon collapse of the C&#x02032;&#x003b1; oxyanion, N5-acyl-FMN<sub>red</sub> results via a series of bond rearrangements. This species has a hydroquinone-like structure, with the acyl moiety protruding out of the plane defined by the isoalloxazine ring of FMN<sub>ox</sub> [Fig. 2<xref ref-type="fig" rid="fig2"> &#x025b8;</xref>(<italic>a</italic>)].</p><p>The UV&#x02013;Vis spectrum of the Y128F mutant protein solution exhibits a typical FMN<sub>ox</sub> absorbance profile [two absorbances at 370 and 450&#x02005;nm; Fig. 4<xref ref-type="fig" rid="fig4"> &#x025b8;</xref>(<italic>a</italic>), i]. FMN<sub>ox</sub> turned colorless when phenylpyruvate was added to the solution, suggesting the formation of an acyl-FMN species [Fig. 4<xref ref-type="fig" rid="fig4"> &#x025b8;</xref>(<italic>a</italic>), ii]. The spectrum is dissimilar to that observed when phenyllactate was added [in which the two typical absorbances at 370 and 450&#x02005;nm disappeared, suggesting the reduction of FMN<sub>ox</sub> to FMN<sub>red</sub>; Fig. 4<xref ref-type="fig" rid="fig4"> &#x025b8;</xref>(<italic>a</italic>), iv] by a small hump at 340&#x02005;nm [Fig. 4<xref ref-type="fig" rid="fig4"> &#x025b8;</xref>(<italic>a</italic>), ii]. The redissolved solution of Y128F mutant crystals/crystalloids that had been pre-soaked with phenylpyruvate also turned colorless, with a profile similar to that in solution [with a smaller hump at 340&#x02005;nm; Fig. 4<xref ref-type="fig" rid="fig4"> &#x025b8;</xref>(<italic>a</italic>), iii] (Sucharitakul <italic>et al.</italic>, 2007<xref ref-type="bibr" rid="bb28"> &#x025b8;</xref>; Thotsaporn <italic>et al.</italic>, 2011<xref ref-type="bibr" rid="bb30"> &#x025b8;</xref>). While O<sub>2</sub> is a small hydrophobic molecule that freely diffuses through spaces and tunnels in protein matrices (Baron, McCammon <italic>et al.</italic>, 2009<xref ref-type="bibr" rid="bb2"> &#x025b8;</xref>; Baron, Riley <italic>et al.</italic>, 2009<xref ref-type="bibr" rid="bb3"> &#x025b8;</xref>), Hmo may have evolved a discrete channel or pockets that temporarily limit the access of O<sub>2</sub> to C4&#x003b1; of N5-acylated isoalloxazine. The metastable N5-alkyl-FMN<sub>red</sub> in aqueous solution is thus attributable to dysfunction of the charge-transfer cage in the absence of Hmo or its Y128F mutant. The inhibited Hmo and mutants identified here differ from the conventional inactivation of FMN<sub>ox</sub>, which requires chemically activated agents (Walsh, 1980<xref ref-type="bibr" rid="bb33"> &#x025b8;</xref>, 1984<xref ref-type="bibr" rid="bb35"> &#x025b8;</xref>).</p></sec><sec id="sec3.2"><label>3.2.</label><title>5-Deaza-FMN in oxidation &#x000a0; </title><p>A photoreduction mechanism has been proposed for the LMO-mediated oxidative decarboxylation reaction (Ghisla &#x00026; Massey, 1977<xref ref-type="bibr" rid="bb12"> &#x025b8;</xref>, 1989<xref ref-type="bibr" rid="bb13"> &#x025b8;</xref>; Ghisla <italic>et al.</italic>, 1979<xref ref-type="bibr" rid="bb14"> &#x025b8;</xref>), in which the reactants need to be activated by photosensitization. In the present case (Hmo and its Y128F mutant), the C4&#x003b1;<sup>+</sup>&#x02212;N5<sup>&#x02212;</sup> ylide of FMN<sub>ox</sub> appears to be the key factor. To validate this proposition, we chemoenzymatically synthesized 1&#x02005;g of the FMN analog 3,10-dimethyl-5-deaza-isoalloxazine ribitol phosphate (5-deaza-FMN<sub>ox</sub>) following previously reported methods [Fig. 4<xref ref-type="fig" rid="fig4"> &#x025b8;</xref>(<italic>b</italic>); the modified method is described in the <ext-link ext-link-type="uri" xlink:href="#suppinfoanchor">supporting information</ext-link>] (Carlson &#x00026; Kiessling, 2004<xref ref-type="bibr" rid="bb5"> &#x025b8;</xref>; Kittleman <italic>et al.</italic>, 2007<xref ref-type="bibr" rid="bb18"> &#x025b8;</xref>; Mansurova <italic>et al.</italic>, 2008<xref ref-type="bibr" rid="bb21"> &#x025b8;</xref>; Osborne <italic>et al.</italic>, 2000<xref ref-type="bibr" rid="bb24"> &#x025b8;</xref>). Biochemically, 5-deaza-FMN-containing Hmo or its Y128F mutant is able to oxidize (<italic>S</italic>)-mandelate to benzoylformate but not to benzoate, confirming that the enzyme was refolded successfully as the wild type and supporting N5 as the pivotal factor in the oxidative decarboxylation reaction [Fig. 4<xref ref-type="fig" rid="fig4"> &#x025b8;</xref>(<italic>c</italic>)]. Similarly, benzoylformate but not benzoate was found in 5-deaza-FMN<sub>ox</sub>-containing crystals of Hmo or its Y128F mutant soaked with (<italic>S</italic>)-mandelate [Figs. 4<xref ref-type="fig" rid="fig4"> &#x025b8;</xref>(<italic>d</italic>) and 4<xref ref-type="fig" rid="fig4"> &#x025b8;</xref>(<italic>e</italic>)]. No N5-acyl adducts can be found in 5-deaza-FMN-containing crystals of Hmo or its Y128F mutant soaked with benzoylformate or phenylpyruvate at various concentrations at different time intervals. Furthermore, the lack of visible electron density at the top of C5 or between C5 and C&#x02032;&#x003b1; of benzoylformate (4.0&#x02005;&#x000c5;) suggests that the C4&#x003b1;=C5 double bond in 5-deaza-FMN is less polarizable. Our structural interrogation supports the decarboxylation of the &#x003b1;-ketoacid taking place after or in concert with the formation of the C&#x02032;&#x003b1;&#x02013;N5 bond. The R163L mutant (a low-activity mutant) was further examined using the&#x000a0;nondecarboxylable substrates &#x003b1;-(<italic>S</italic>)-mandelamide [2-(<italic>S</italic>)-hydroxy-2-phenylethylamide] or benzoylamide (2-keto-2-phenylethylamide), in which the former is oxidized to form the latter. When the R163L mutant crystals were soaked with benzoylamide, an &#x003b1;-hydroxyamide-FMN adduct was formed [Fig. 4<xref ref-type="fig" rid="fig4"> &#x025b8;</xref>(<italic>f</italic>)], leading to the unequivocal conclusion that N5 of FMN<sub>ox</sub> has a nucleophilic propensity and that the C&#x02032;&#x003b1;&#x02014;N5 bond is formed prior to &#x003b1;-ketoacid decarboxylation.</p></sec><sec id="sec3.3"><label>3.3.</label><title>Four-electron oxidation to benzoate &#x000a0; </title><p>We propose that C4&#x003b1;-OOH-N5-acyl-FMN is the key intermediate in the four-electron oxidation of an &#x003b1;-hydroxyacid mediated by Hmo and its Y128F mutant on the basis of the following facts: (i) Hmo and its Y128F mutant catalyze the four-electron oxidation of an &#x003b1;-hydroxyacid via an &#x003b1;-ketoacid to an acid with one O atom from O<sub>2</sub> incorporated into the terminal carboxylic group, (ii) H<sub>2</sub>O<sub>2</sub> is not able to oxidize the &#x003b1;-ketoacid in the absence of Hmo or its Y128F mutant, (iii) the <italic>pro-R</italic> &#x003b1;-ketoacid is covalently linked to FMN<sub>ox</sub> in the Y128F mutant, forming an N5-acyl-FMN<sub>red</sub> adduct, (iv) the oxidation cascade stalls at the &#x003b1;-ketoacid using Hmo or its Y128F mutant with 5-deaza-FMN<sub>ox</sub> in lieu of FMN<sub>ox</sub> and (v) the <italic>sp</italic>
<sup>3</sup> N5 in FMN<sub>red</sub> is highly reactive, as exemplified in UbiX, a flavin prenyltransferase involved in bacterial ubiquinone biosynthesis (White <italic>et al.</italic>, 2015<xref ref-type="bibr" rid="bb37"> &#x025b8;</xref>). The formation of the intermediate is somewhat similar to the mechanism proposed for EncM, which catalyses an oxidative Favorskii-type re&#x000ad;arrangement reaction (Teufel <italic>et al.</italic>, 2015<xref ref-type="bibr" rid="bb29"> &#x025b8;</xref>). The major discrepancy, however, is that O<sub>2</sub> in Hmo and its Y128F mutant mediates the transient formation of C4&#x003b1;-OOH-N5-acyl-FMN prior to its release as H<sub>2</sub>O<sub>2</sub>.</p><p>Superposition of the benzoylformate-liganded ternary complex of the Y128F mutant with that of the wild type shows no apparent discrepancies (r.m.s.d. of 0.06&#x02005;&#x000c5;) except for the <italic>p</italic>-OH group of Tyr128 (<ext-link ext-link-type="uri" xlink:href="#suppinfoanchor">Supplementary Fig. S4</ext-link>). Given that the oxidative decarboxylation of an &#x003b1;-hydroxyacid is cata&#x000ad;lytically executed by the Y128F mutant, the <italic>p</italic>-OH group ought to play a crucial role in leverage of the oxidation cascade. This effect is commensurate with a recent report that a single mutation, C65D, of phenylacetone monooxygenase converts a monooxygenase to an oxidase (in contrast to this report) by facilitating the discharge of H<sub>2</sub>O<sub>2</sub> (Brondani <italic>et al.</italic>, 2014<xref ref-type="bibr" rid="bb4"> &#x025b8;</xref>). C4&#x003b1;-OOH-FMN<sub>red</sub>, which is a reactive intermediate in a typical monooxygenase/oxidase-catalyzed reaction, was modeled and optimized in the structure of Hmo, in which the <italic>p</italic>-OH group is within hydrogen-bonding distance (2.7&#x02005;&#x000c5;) of C4&#x003b1;-OOH [Fig.&#x000a0;3<xref ref-type="fig" rid="fig3"> &#x025b8;</xref>(<italic>e</italic>)]. On the basis of this model, the <italic>p</italic>-OH group is in a position to protonate C4&#x003b1;-OO<sup>&#x02212;</sup>-FMN<sub>red</sub> to form C4&#x003b1;-OOH-FMN<sub>red</sub>, thereby neutralizing or facilitating the discharge of H<sub>2</sub>O<sub>2</sub> from C4&#x003b1;-OOH. In contrast, C4&#x003b1;-OO<sup>&#x02212;</sup>-FMN<sub>red</sub> may diverge in the absence of the <italic>p</italic>-OH group. One implication is that the Y128F mutant works like a monooxygenase, whereby Baeyer&#x02013;Villiger-type reactions result. That is, the C4&#x003b1;-OO<sup>&#x02212;</sup> anion attacks the &#x003b1;-carbon (C&#x02032;&#x003b1;) of <italic>pro-R</italic> benzoylformate to form a tetrahedral oxyanion species. Upon the collapse of the &#x003b1;-oxyanion the terminal carboxyl group migrates to the distal O atom of C4&#x003b1;-OO<sup>&#x02212;</sup> to form a mixed-anhydride species; subsequent hydrolysis would give rise to benzoate and formate (Torres Pazmi&#x000f1;o <italic>et al.</italic>, 2010<xref ref-type="bibr" rid="bb31"> &#x025b8;</xref>). This type of reaction, however, was ruled out because no benzoate was detected in the reactions catalyzed by the 5-deaza-FMN-containing Y128F mutant. This fact, however, underscores the importance of the <italic>sp</italic>
<sup>3</sup> N5 of C4&#x003b1;-OO<sup>&#x02212;</sup>-FMN<sub>red</sub> in the four-electron oxidation reaction, where the reduced or polarized <italic>sp</italic>
<sup>3</sup> N5 actually has a better B&#x000fc;rgi&#x02013;Dunitz angle and is at a short distance from C&#x02032;&#x003b1; of <italic>pro-R</italic> benzoylformate, favoring the formation of C4&#x003b1;-OO<sup>&#x02212;</sup>-N5-alkyl-FMN<sub>red</sub> before the release of H<sub>2</sub>O<sub>2</sub>.</p></sec><sec id="sec3.4"><label>3.4.</label><title>Proposed catalytic mechanism of oxidative decarboxylation &#x000a0; </title><p>In a general four-electron oxidation reaction, one molecule of (<italic>S</italic>)-mandelate should theoretically yield two equivalents of H<sub>2</sub>O<sub>2</sub>. The molar ratio of H<sub>2</sub>O<sub>2</sub> versus benzoate, however, did not follow this stoichiometry (it was much less than unity; Yeh <italic>et al.</italic>, 2019<xref ref-type="bibr" rid="bb39"> &#x025b8;</xref>). This fact, in contrast, is consistent with a disproportionation reaction of FMN peroxide, in which one O atom goes to benzoate and the other ends up as water. To search for clues, we re-examined the active-site geometry of Hmo and its Y128F mutant liganded with substrates (mandelate or lactate) or products (benzoylformate or pyruvate). The redox-active center C4&#x003b1;=N5 of isoalloxazine is surrounded by a constellation of active-site residues [Val78 and Ala79 at the bottom and Tyr(Phe)128 and His252 at the top], where it is accessible only from the upper front side. The reaction center is sealed to form a narrow and low-dielectric milieu suitable for hydride transfer/electron tunneling when a substrate and redox-active center C4&#x003b1;=N5 approach each other. Interestingly, the substrate pair mandelate/benzoyl&#x000ad;formate fits better than the alternative pair lactate/pyruvate because of the bulky phenyl group in the former [Figs. 3<xref ref-type="fig" rid="fig3"> &#x025b8;</xref>(<italic>f</italic>) and 3<xref ref-type="fig" rid="fig3"> &#x025b8;</xref>(<italic>g</italic>)]. The redox chamber in the Y128F mutant, on the other hand, is not as tight as that in the wild type owing to the lack of the <italic>p</italic>-OH group [Fig. 3<xref ref-type="fig" rid="fig3"> &#x025b8;</xref>(<italic>h</italic>)]. This flaw is exacerbated when lactate (with a smaller methyl group) is used [Figs. 3<xref ref-type="fig" rid="fig3"> &#x025b8;</xref>(<italic>f</italic>) and 3<xref ref-type="fig" rid="fig3"> &#x025b8;</xref>(<italic>g</italic>)]. In this context, O<sub>2</sub> is relatively accessible to FMN<sub>red</sub> via a temporal space/tunnel to form C4&#x003b1;-OO<sup>&#x02212;</sup>-FMN before the release of the &#x003b1;-ketoacid (the non-ping-pong mechanism). Meanwhile, the <italic>pro</italic>-<italic>R</italic> &#x003b1;-ketoacid is accessible by <italic>sp</italic>
<sup>3</sup> N5 to form C4&#x003b1;-COOH-N5-oxyalkylate-FMN<sub>red</sub>. Upon decarboxyl&#x000ad;ation, a C4&#x003b1;-COOH-N5-aloxyl-FMN<sub>red</sub> C&#x02032;&#x003b1; carb&#x000ad;anion results. The C&#x02032;&#x003b1; carbanion that intramolecularly attacks the distal O atom of C4&#x003b1;-OOH then leads to heterolytic cleavage of the peroxide scissile bond. Upon return of the C&#x02032;&#x003b1; oxyanion, benzoate and H<sub>2</sub>O are formed in concert with the regeneration of FMN<sub>ox</sub> (Fig. 5<xref ref-type="fig" rid="fig5"> &#x025b8;</xref>).</p><p>The peroxide anion radical:FMN semiquinone caged pair is likely to proceed through a single-electron transfer from FMN<sub>red</sub> to O<sub>2</sub> in a given flavoenzyme, where the reactivity depends on the active-site polarity ensemble of factors including bound water, charge distribution, hydrogen bonds, van der Waal forces <italic>etc.</italic> (Fagan &#x00026; Palfey, 2010<xref ref-type="bibr" rid="bb11"> &#x025b8;</xref>). The Y128C mutant (in which the bulky phenyl group is replaced by a sulfhydryl group) that can transform (<italic>S</italic>)-mandelate to benzoate was used to assess the extent of active-site perturbation. The structure of the Y128C mutant crystallized and soaked with (<italic>S</italic>)-mandelate revealed that the sulfhydryl (SH) group of the Y128C mutant has been oxidized to a sulfenyl group (S-OH), in contrast to the other sulfhydryl groups, which are not changed [Fig. 3<xref ref-type="fig" rid="fig3"> &#x025b8;</xref>(<italic>i</italic>)]. This result indicates that the sulfhydryl group of the Y128C mutant is relatively accessible and sensitive to the local unregulated reactive oxygen species (ROS; Chaiyen <italic>et al.</italic>, 2012<xref ref-type="bibr" rid="bb6"> &#x025b8;</xref>).</p></sec></sec><sec sec-type="conclusions" id="sec4"><label>4.</label><title>Conclusions &#x000a0; </title><p>The present studies allow us to gain mechanistic insights into the reactions catalyzed by both Hmo and its Y128F mutant, in which substrate reorientation, active-site perturbation and spatiotemporal crowdedness are pivotal factors that influence the dioxygen accessibility and reaction order of the FMN<sub>red/ox</sub>:&#x003b1;-ketoacid pair in the reactions mediated by Hmo and its Y128F mutant. Given the Y128F mutation, the original reactivity of Hmo is perturbed. One stark contrast is that the electrophilic FMN<sub>ox</sub> is polarizable to an ylide-like species. This species is capable of attacking an &#x003b1;-ketoacid to form an N5-acyl-FMN<sub>red</sub> dead-end adduct, providing evidence for the first time that FMN<sub>ox</sub> possesses a nucleophilic/electrophilic duality. Having confirmed the formation of the N5-acyl-FMN<sub>red</sub> adduct, both the nucleophilic propensity and positional preponderance of N5 of FMN<sub>red</sub> prompt us to propose that the N5-alkanol-FMN<sub>red</sub> C&#x02032;&#x003b1; carbanion is the key intermediate in the oxidative decarboxylation reaction. This intermediate reacts with dioxygen in place to form a C4&#x003b1;-COOH-N5-aloxyl-FMN<sub>red</sub> C&#x02032;&#x003b1; carbanion species that subsequently undergoes an intramolecular disproportionation reaction to yield benzoate and FMN<sub>ox</sub>, thus accounting for the ThDP/PLP/NADPH-independent oxidative decarboxylation reaction. To this end, the <italic>p</italic>-OH group of Tyr128 that leverages the spatial and temporal leeway over the oxidation cascade was unexpected. The &#x003b1;-substituent on the &#x003b1;-hydroxy acid that influences the accessibility of dioxygen to the reaction center is another unexpected factor. A synthetic 5-deaza-FMN<sub>ox</sub> cofactor in combination with an &#x003b1;-hydroxyamide or &#x003b1;-keto&#x000ad;amide positively supports the proposed mechanism, in which the loose ends that benzoate is a minor product of Hmo and the major product of the Y128F mutant are tied up. An unequivocal consolidation of the proposed mechanism would be provided by the physical capture or visualization of the C4&#x003b1;-COOH-N5-aloxyl-FMN<sub>red</sub> C&#x02032;&#x003b1; carbanion or other relevant intermediates, which however will require future studies using advanced spectroscopic and microscopic analysis on the submicrosecond time scale using, for example, the X-ray free-electron laser technique. The present structural and biochemical elucidation nonetheless strengthens the idea that the FMN cofactor is versatile and cooperates with the active-site residues and substrates in dictating the oxidation cascade.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data"><p>PDB reference: <ext-link ext-link-type="pdb" xlink:href="5zzp"><italic>p</italic>-hydroxymandelate oxidase, 5zzp</ext-link>
</p></supplementary-material><supplementary-material content-type="local-data"><p>PDB reference: <ext-link ext-link-type="pdb" xlink:href="5zzr">complex with (<italic>S</italic>)-mandelate, 5zzr</ext-link>
</p></supplementary-material><supplementary-material content-type="local-data"><p>PDB reference: <ext-link ext-link-type="pdb" xlink:href="6a08">complex with benzoylformate, 6a08</ext-link>
</p></supplementary-material><supplementary-material content-type="local-data"><p>PDB reference: <ext-link ext-link-type="pdb" xlink:href="5zzz">Y128C mutant, complex with benzoylformate, 5zzz</ext-link>
</p></supplementary-material><supplementary-material content-type="local-data"><p>PDB reference: <ext-link ext-link-type="pdb" xlink:href="6a13">Y128F mutant, 6a13</ext-link>
</p></supplementary-material><supplementary-material content-type="local-data"><p>PDB reference: <ext-link ext-link-type="pdb" xlink:href="6a0v">complex with (<italic>S</italic>)-mandelate, 6a0v</ext-link>
</p></supplementary-material><supplementary-material content-type="local-data"><p>PDB reference: <ext-link ext-link-type="pdb" xlink:href="6a1h">complex with 5-deazariboflavin mononucleotide, 6a1h</ext-link>
</p></supplementary-material><supplementary-material content-type="local-data"><p>PDB reference: <ext-link ext-link-type="pdb" xlink:href="6a1l">complex with 5-deazariboflavin mononucleotide and benzoic acid, 6a1l</ext-link>
</p></supplementary-material><supplementary-material content-type="local-data"><p>PDB reference: <ext-link ext-link-type="pdb" xlink:href="6a1m">complex with 5-deazariboflavin mononucleotide and benzoylformate, 6a1m</ext-link>
</p></supplementary-material><supplementary-material content-type="local-data"><p>PDB reference: <ext-link ext-link-type="pdb" xlink:href="6a1p">complex with 5-deazariboflavin mononucleotide and phenylpyruvate, 6a1p</ext-link>
</p></supplementary-material><supplementary-material content-type="local-data"><p>PDB reference: <ext-link ext-link-type="pdb" xlink:href="6a1r">complex with phenylpyruvate and riboflavin mononucleotide, 6a1r</ext-link>
</p></supplementary-material><supplementary-material content-type="local-data"><p>PDB reference: <ext-link ext-link-type="pdb" xlink:href="6a19">complex with benzoylformate, 6a19</ext-link>
</p></supplementary-material><supplementary-material content-type="local-data"><p>PDB reference: <ext-link ext-link-type="pdb" xlink:href="6a21">complex with malonyl&#x02013;riboflavin mononucleotide, 6a21</ext-link>
</p></supplementary-material><supplementary-material content-type="local-data"><p>PDB reference: <ext-link ext-link-type="pdb" xlink:href="6a23">complex with benzoylformate and riboflavin mononucleotide, 6a23</ext-link>
</p></supplementary-material><supplementary-material content-type="local-data"><p>PDB reference: <ext-link ext-link-type="pdb" xlink:href="6a3t">R163L mutant, complex with mandelamide&#x02013;riboflavin mononucleotide, 6a3t</ext-link>
</p></supplementary-material><supplementary-material content-type="local-data"><p>Chemical syntheses, supporting figures and table. DOI: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1107/S2059798319011938/ag5031sup1.pdf">10.1107/S2059798319011938/ag5031sup1.pdf</ext-link>
</p><media mimetype="application" mime-subtype="pdf" xlink:href="d-75-00918-sup1.pdf" orientation="portrait" id="d35e316" position="anchor"/></supplementary-material></sec></body><back><ack><p>Portions of this research were carried out at the National Synchrotron Radiation Research Center (NSRRC), a national user facility supported by MOST of Taiwan, ROC. We thank both NSRRC in Taiwan and SPring-8 in Japan for beam-time allocations at beamlines 13C, 13B, 05A, 15A and 44XU.</p></ack><ref-list><title>References</title><ref id="bb1"><mixed-citation publication-type="other">Afonine, P. V., Grosse-Kunstleve, R. W., Echols, N., Headd, J. J., Moriarty, N. W., Mustyakimov, M., Terwilliger, T. C., Urzhumtsev, A., Zwart, P. H. &#x00026; Adams, P. D. (2012). <italic>Acta Cryst.</italic> D<bold>68</bold>, 352&#x02013;367.</mixed-citation></ref><ref id="bb2"><mixed-citation publication-type="other">Baron, R., McCammon, J. A. &#x00026; Mattevi, A. (2009). <italic>Curr. Opin. Struct. Biol.</italic>
<bold>19</bold>, 672&#x02013;679.</mixed-citation></ref><ref id="bb3"><mixed-citation publication-type="other">Baron, R., Riley, C., Chenprakhon, P., Thotsaporn, K., Winter, R. T., Alfieri, A., Forneris, F., van Berkel, W. J., Chaiyen, P., Fraaije, M. W., Mattevi, A. &#x00026; McCammon, J. A. (2009). <italic>Proc. Natl Acad. Sci. USA</italic>, <bold>106</bold>, 10603&#x02013;10608.</mixed-citation></ref><ref id="bb4"><mixed-citation publication-type="other">Brondani, P. B., Dudek, H. M., Martinoli, C., Mattevi, A. &#x00026; Fraaije, M. W. (2014). <italic>J. Am. Chem. Soc.</italic>
<bold>136</bold>, 16966&#x02013;16969.</mixed-citation></ref><ref id="bb5"><mixed-citation publication-type="other">Carlson, E. E. &#x00026; Kiessling, L. L. (2004). <italic>J. Org. Chem.</italic>
<bold>69</bold>, 2614&#x02013;2617.</mixed-citation></ref><ref id="bb6"><mixed-citation publication-type="other">Chaiyen, P., Fraaije, M. W. &#x00026; Mattevi, A. (2012). <italic>Trends Biochem. Sci.</italic>
<bold>37</bold>, 373&#x02013;380.</mixed-citation></ref><ref id="bb41"><mixed-citation publication-type="other">Chen, Z.-W., Vignaud, C., Jaafar, A., Levy, B., Gueritte, F., Guenard, D., Lederer, F. &#x00026; Mathews, F. S. (2012). <italic>Biochimie</italic>, <bold>94</bold>, 1172&#x02013;1179.</mixed-citation></ref><ref id="bb7"><mixed-citation publication-type="other">Choong, Y. S. &#x00026; Massey, V. (1980). <italic>J. Biol. Chem.</italic>
<bold>255</bold>, 8672&#x02013;8677.</mixed-citation></ref><ref id="bb8"><mixed-citation publication-type="other">Dai, X., Mashiguchi, K., Chen, Q. G., Kasahara, H., Kamiya, Y., Ojha, S., DuBois, J., Ballou, D. &#x00026; Zhao, Y. (2013). <italic>J. Biol. Chem.</italic>
<bold>288</bold>, 1448&#x02013;1457.</mixed-citation></ref><ref id="bb9"><mixed-citation publication-type="other">DeLano, W. L. (2002). <italic>PyMOL</italic>. http://www.pymol.org.</mixed-citation></ref><ref id="bb10"><mixed-citation publication-type="other">Emsley, P., Lohkamp, B., Scott, W. G. &#x00026; Cowtan, K. (2010). <italic>Acta Cryst.</italic> D<bold>66</bold>, 486&#x02013;501.</mixed-citation></ref><ref id="bb11"><mixed-citation publication-type="other">Fagan, R. L. &#x00026; Palfey, B. A. (2010). <italic>Comprehensive Natural Products II: Chemistry and Biology</italic>, edited by H.-W. Liu &#x00026; L. Mander, Vol. 7, pp. 37&#x02013;113. Kidlington: Elsevier.</mixed-citation></ref><ref id="bb12"><mixed-citation publication-type="other">Ghisla, S. &#x00026; Massey, V. (1977). <italic>J. Biol. Chem.</italic>
<bold>252</bold>, 6729&#x02013;6735.</mixed-citation></ref><ref id="bb13"><mixed-citation publication-type="other">Ghisla, S. &#x00026; Massey, V. (1989). <italic>Eur. J. Biochem.</italic>
<bold>181</bold>, 1&#x02013;17.</mixed-citation></ref><ref id="bb14"><mixed-citation publication-type="other">Ghisla, S., Massey, V. &#x00026; Choong, Y. S. (1979). <italic>J. Biol. Chem.</italic>
<bold>254</bold>, 10662&#x02013;10669.</mixed-citation></ref><ref id="bb15"><mixed-citation publication-type="other">Giegel, D. A., Williams, C. H. &#x00026; Massey, V. (1990). <italic>J. Biol. Chem.</italic>
<bold>265</bold>, 6626&#x02013;6632.</mixed-citation></ref><ref id="bb16"><mixed-citation publication-type="other">Hefti, M. H., Milder, F. J., Boeren, S., Vervoort, J. &#x00026; van Berkel, W. J. (2003). <italic>Biochim. Biophys. Acta</italic>, <bold>1619</bold>, 139&#x02013;143.</mixed-citation></ref><ref id="bb17"><mixed-citation publication-type="other">Heroux, A., Bozinovski, D. M., Valley, M. P., Fitzpatrick, P. F. &#x00026; Orville, A. M. (2009). <italic>Biochemistry</italic>, <bold>48</bold>, 3407&#x02013;3416.</mixed-citation></ref><ref id="bb18"><mixed-citation publication-type="other">Kittleman, W., Thibodeaux, C. J., Liu, Y.-N., Zhang, H. &#x00026; Liu, H.-W. (2007). <italic>Biochemistry</italic>, <bold>46</bold>, 8401&#x02013;8413.</mixed-citation></ref><ref id="bb19"><mixed-citation publication-type="other">Lockridge, O., Massey, V. &#x00026; Sullivan, P. A. (1972). <italic>J. Biol. Chem.</italic>
<bold>247</bold>, 8097&#x02013;8106.</mixed-citation></ref><ref id="bb20"><mixed-citation publication-type="other">Lopalco, A., Dalwadi, G., Niu, S., Schowen, R. L., Douglas, J. &#x00026; Stella, V. J. (2016). <italic>J. Pharm. Sci.</italic>
<bold>105</bold>, 705&#x02013;713.</mixed-citation></ref><ref id="bb21"><mixed-citation publication-type="other">Mansurova, M., Koay, M. S. &#x00026; G&#x000e4;rtner, W. (2008). <italic>Eur. J. Org. Chem.</italic>
<bold>2008</bold>, 5401&#x02013;5406.</mixed-citation></ref><ref id="bb22"><mixed-citation publication-type="other">McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C. &#x00026; Read, R. J. (2007). <italic>J. Appl. Cryst.</italic>
<bold>40</bold>, 658&#x02013;674.</mixed-citation></ref><ref id="bb23"><mixed-citation publication-type="other">Milczek, E. M., Bonivento, D., Binda, C., Mattevi, A., McDonald, I. A. &#x00026; Edmondson, D. E. (2008). <italic>J. Med. Chem.</italic>
<bold>51</bold>, 8019&#x02013;8026.</mixed-citation></ref><ref id="bb50"><mixed-citation publication-type="other">Murshudov, G. N., Skub&#x000e1;k, P., Lebedev, A. A., Pannu, N. S., Steiner, R. A., Nicholls, R. A., Winn, M. D., Long, F. &#x00026; Vagin, A. A. (2011). <italic>Acta Cryst.</italic> D<bold>67</bold>, 355&#x02013;367.</mixed-citation></ref><ref id="bb24"><mixed-citation publication-type="other">Osborne, A., Thorneley, R. N., Abell, C. &#x00026; Bornemann, S. (2000). <italic>J. Biol. Chem.</italic>
<bold>275</bold>, 35825&#x02013;35830.</mixed-citation></ref><ref id="bb25"><mixed-citation publication-type="other">Otwinowski, Z. &#x00026; Minor, W. (1997). <italic>Methods Enzymol.</italic>
<bold>276</bold>, 307&#x02013;326.</mixed-citation></ref><ref id="bb26"><mixed-citation publication-type="other">Razeto, A., Mattiroli, F., Carpanelli, E., Aliverti, A., Pandini, V., Coda, A. &#x00026; Mattevi, A. (2007). <italic>Structure</italic>, <bold>15</bold>, 683&#x02013;692.</mixed-citation></ref><ref id="bb27"><mixed-citation publication-type="other">Stepanova, A. N., Yun, J., Robles, L. M., Novak, O., He, W., Guo, H., Ljung, K. &#x00026; Alonso, J. M. (2011). <italic>Plant Cell</italic>, <bold>23</bold>, 3961&#x02013;3973.</mixed-citation></ref><ref id="bb28"><mixed-citation publication-type="other">Sucharitakul, J., Phongsak, T., Entsch, B., Svasti, J., Chaiyen, P. &#x00026; Ballou, D. P. (2007). <italic>Biochemistry</italic>, <bold>46</bold>, 8611&#x02013;8623.</mixed-citation></ref><ref id="bb29"><mixed-citation publication-type="other">Teufel, R., Stull, F., Meehan, M. J., Michaudel, Q., Dorrestein, P. C., Palfey, B. &#x00026; Moore, B. S. (2015). <italic>J. Am. Chem. Soc.</italic>
<bold>137</bold>, 8078&#x02013;8085.</mixed-citation></ref><ref id="bb30"><mixed-citation publication-type="other">Thotsaporn, K., Chenprakhon, P., Sucharitakul, J., Mattevi, A. &#x00026; Chaiyen, P. (2011). <italic>J. Biol. Chem.</italic>
<bold>286</bold>, 28170&#x02013;28180.</mixed-citation></ref><ref id="bb31"><mixed-citation publication-type="other">Torres Pazmi&#x000f1;o, D. E., Dudek, H. M. &#x00026; Fraaije, M. W. (2010). <italic>Curr. Opin. Chem. Biol.</italic>
<bold>14</bold>, 138&#x02013;144.</mixed-citation></ref><ref id="bb33"><mixed-citation publication-type="other">Walsh, C. (1980). <italic>Mol. Biol. Biochem. Biophys.</italic>
<bold>32</bold>, 62&#x02013;77.</mixed-citation></ref><ref id="bb34"><mixed-citation publication-type="other">Walsh, C., Lockridge, O., Massey, V. &#x00026; Abeles, R. (1973). <italic>J. Biol. Chem.</italic>
<bold>248</bold>, 7049&#x02013;7054.</mixed-citation></ref><ref id="bb35"><mixed-citation publication-type="other">Walsh, C. T. (1984). <italic>Annu. Rev. Biochem.</italic>
<bold>53</bold>, 493&#x02013;535.</mixed-citation></ref><ref id="bb36"><mixed-citation publication-type="other">Walsh, C. T. &#x00026; Wencewicz, T. A. (2013). <italic>Nat. Prod. Rep.</italic>
<bold>30</bold>, 175&#x02013;200.</mixed-citation></ref><ref id="bb37"><mixed-citation publication-type="other">White, M. D., Payne, K. A. P., Fisher, K., Marshall, S. A., Parker, D., Rattray, N. J. W., Trivedi, D. K., Goodacre, R., Rigby, S. E. J., Scrutton, N. S., Hay, S. &#x00026; Leys, D. (2015). <italic>Nature (London)</italic>, <bold>522</bold>, 502&#x02013;506.</mixed-citation></ref><ref id="bb40"><mixed-citation publication-type="other">Winn, M. D., Ballard, C. C., Cowtan, K. D., Dodson, E. J., Emsley, P., Evans, P. R., Keegan, R. M., Krissinel, E. B., Leslie, A. G. W., McCoy, A., McNicholas, S. J., Murshudov, G. N., Pannu, N. S., Potterton, E. A., Powell, H. R., Read, R. J., Vagin, A. &#x00026; Wilson, K. S. (2011). <italic>Acta Cryst.</italic> D<bold>67</bold>, 235&#x02013;242.</mixed-citation></ref><ref id="bb38"><mixed-citation publication-type="other">Wu, T., Ling, K.-Q., Sayre, L. M. &#x00026; McIntire, W. S. (2005). <italic>Biochem. Biophys. Res. Commun.</italic>
<bold>326</bold>, 483&#x02013;490.</mixed-citation></ref><ref id="bb39"><mixed-citation publication-type="other">Yeh, H.-W., Lin, K.-H., Lyu, S.-Y., Li, Y.-S., Huang, C.-M., Wang, Y.-L., Shih, H.-W., Hsu, N.-S., Wu, C.-J. &#x00026; Li, T.-L. (2019). <italic>Acta Cryst.</italic> D<bold>75</bold>, 733&#x02013;742.</mixed-citation></ref></ref-list></back><floats-group><fig id="fig1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>The oxidation reactions catalyzed by Hmo and its Y128F mutant. (<italic>a</italic>) Hmo catalyzes a two-electron oxidation reaction to form benzoylformate from (<italic>S</italic>)-mandelate. (<italic>b</italic>) The Y128F mutant catalyzes a four-electron oxidative decarboxylation reaction from (<italic>S</italic>)-mandelate to benzoylformate and benzoic acid without freeing H<sub>2</sub>O<sub>2</sub> during the reaction. (<italic>c</italic>) When benzoylformate is used as the substrate, the decarboxylated product benzoic acid cannot be formed by Hmo or its Y128F mutant in the presence or absence of H<sub>2</sub>O<sub>2</sub>.</p></caption><graphic xlink:href="d-75-00918-fig1"/></fig><fig id="fig2" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Crystal structures of acyl-FMN<sub>red</sub> adducts and inhibition mechanism by &#x003b1;-ketoacids. (<italic>a</italic>) Structures of acyl-FMN<sub>red</sub> adducts in crystals of the Y128F mutant soaked with benzoylformate (left), phenylpyruvate (center) or oxaloacetate (right). The flavin adducts all are at the <italic>si</italic>-face of the isoalloxazine ring. (<italic>b</italic>) LC traces and mass spectra of FMN (i) and phenylacetyl-FMN<sub>red</sub> (ii). (<italic>c</italic>, <italic>d</italic>) Weighted 2<italic>F</italic>
<sub>o</sub> &#x02212; <italic>F</italic>
<sub>c</sub> electron-density maps (gray) and unbiased <italic>F</italic>
<sub>o</sub>&#x000a0;&#x02212;&#x000a0;<italic>F</italic>
<sub>c</sub> difference OMIT electron-density maps (blue) for FMN in Hmo (<italic>c</italic>) and the Y128F mutant (<italic>d</italic>) without (left) or with a ligand (<italic>S</italic>-mandelate, center; benzoylformate, right), where the extent of polarization is justified by OMIT electron density (the wild type or Y128F mutant and the absence or presence of a ligand seem to be key factors). The 2<italic>F</italic>
<sub>o</sub> &#x02212; <italic>F</italic>
<sub>c</sub> electron-density map is contoured at 2&#x003c3;; the unbiased <italic>F</italic>
<sub>o</sub> &#x02212; <italic>F</italic>
<sub>c</sub> OMIT difference electron-density map is contoured at 4&#x003c3;. Free ligands, FMN, FMN adducts and active-site residues are colored cyan, yellow, orange and green, respectively. See <ext-link ext-link-type="uri" xlink:href="#suppinfoanchor">Supplementary Figs. S3(<italic>a</italic>)</ext-link>, <ext-link ext-link-type="uri" xlink:href="#suppinfoanchor">S3(<italic>b</italic>)</ext-link> and <ext-link ext-link-type="uri" xlink:href="#suppinfoanchor">S2(<italic>c</italic>)</ext-link> for stereoviews and <italic>F</italic>
<sub>o</sub> &#x02212; <italic>F</italic>
<sub>c</sub> difference electron-density maps.</p></caption><graphic xlink:href="d-75-00918-fig2"/></fig><fig id="fig3" orientation="portrait" position="float"><label>Figure 3</label><caption><p>The effect of 4-OH of Tyr128 on polarization, hydrogen-bond networking and reactivity. (<italic>a</italic>, <italic>b</italic>) A close-up view of the wedge-shaped electron density on top of C4&#x003b1;=N5 of FMN<sub>ox</sub> shown by unbiased difference electron-density maps (blue, positive electron density) contoured at 4&#x003c3; in the wild type (<italic>a</italic>) and the Y128F mutant (<italic>b</italic>), suggesting that the electrons in the &#x003c0;-orbital of C4&#x003b1;=N5 are polarized from C4&#x003b1; to N5 (to form a C4&#x003b1;<sup>+</sup>&#x02013;N5<sup>&#x02212;</sup> ylide), with this being more significant in the Y128F mutant than in the wild type. (<italic>c</italic>, <italic>d</italic>) The point mutation Y128F disturbs the active-site hydrogen-bonding network between water, FMN and the catalytic dyad [the Y128F mutant loses the hydrogen bond between Tyr128 and H<sub>2</sub>O (187) but gains a new hydrogen bond between His252 and H<sub>2</sub>O (257)]. (<italic>e</italic>) Hydrogen peroxide was modeled at C4&#x003b1;, where the distance between Tyr128 and the terminal O atom of C&#x003b1;-OOH is 2.7&#x02005;&#x000c5;. (<italic>f</italic>, <italic>g</italic>) The phenyl ring of benzoylformate, which is bulkier and takes up space, limits the access of dioxygen to the reaction center, while the methyl group of pyruvate, which is smaller and takes up less space, allows the access of dioxygen to the reaction center [the phenyl ring that bulges out at the substrate entrance in (<italic>f</italic>) prohibits exposure of FMN<sub>red</sub> to the bulk solvent, as opposed to the methyl group in (<italic>g</italic>) which allows exposure of FMN<sub>red</sub> to the bulk solvent]. Therefore, the size of the substrates is another factor in leverage of the oxidation cascade. (<italic>h</italic>) Aside from the active-site perturbation effect, the absence of the <italic>p</italic>-&#x000ad;OH group also introduces some space allowing access of O<sub>2</sub> to the C4&#x003b1; redox-active center. (<italic>i</italic>) The sulfhydryl group (SH) of the Y128C mutant has been oxidized to a sulfenyl group (S-OH), as it is vulnerable to ROS generated in the active site. Free ligands, FMN and active-site residues are colored cyan, yellow and green, respectively.</p></caption><graphic xlink:href="d-75-00918-fig3a"/><graphic xlink:href="d-75-00918-fig3b"/></fig><fig id="fig4" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Spectra, synthesis, reaction and structure of 5-deaza-FMN. (<italic>a</italic>) UV&#x02013;Vis spectra of FMN in Hmo and its Y128F mutant: (i) FMN<sub>ox</sub> in Hmo (370/450&#x02005;nm, green line), (ii) acyl-FMN<sub>red</sub> in the Y128F mutant [340&#x02005;nm, blue line; addition of phenylpyruvate (PPY) for 2&#x02005;h], (iii) acylated FMN in redissolved Y128F mutant crystals/crystalloids soaked with PPY (acyl-FMN<sub>red</sub>, 340&#x02005;nm, dotted blue line), (iv) FMN<sub>red</sub> in Hmo [a shoulder at 330&#x02005;nm, red; addition of phenyllactate (PLA)]. (<italic>b</italic>) (i) Chemical synthesis and LC purification of 5-deazariboflavin (the inset shows the mass spectrum of 5-deazariboflavin), (ii) enzymatic synthesis and LC purification of 5-deaza-FMN (the inset shows the mass spectrum of 5-deaza-FMN). (<italic>c</italic>) Enzymatic reactions of Hmo and its Y128F mutant harboring 5-deaza-FMN: (i) enzymatic reaction with Hmo harboring 5-deaza-FMN in the presence of <italic>S</italic>-mandelate, (ii) enzymatic reaction with the Y128F mutant harboring 5-deaza-FMN in the presence of <italic>S</italic>-mandelate, (iii) control reaction of wild-type Hmo in the presence of <italic>S</italic>-mandelate, (iv) control reaction of the Y128F mutant in the presence of <italic>S</italic>-mandelate. (<italic>d</italic>, <italic>e</italic>) Crystal structures of the Y128F mutant harboring 5-deaza-FMN soaked with <italic>S</italic>-mandelate (<italic>d</italic>) or phenyllactate (<italic>e</italic>), which have been transformed into benzoylformate or phenylpyruvate, respectively. Unlike FMN in the wild type or the Y128F mutant, no electron density emerges at the top of C5 or between C&#x02032;&#x003b1; and C5. (<italic>f</italic>) The structure of an &#x003b1;-mandelamide&#x02013;N5-FMN<sub>red</sub> adduct in the crystal of the R163L mutant soaked with nondecarboxylable &#x003b1;-mandelamide (the chemical structure is shown). The flavin adduct is on the <italic>si</italic>-face of the isoalloxazine ring. The 2<italic>F</italic>
<sub>o</sub> &#x02212; <italic>F</italic>
<sub>c</sub> electron-density map is contoured at 2&#x003c3;. The unbiased <italic>F</italic>
<sub>o</sub> &#x02212; <italic>F</italic>
<sub>c</sub> difference electron-density map is contoured at 4&#x003c3; in positive electron density. Free ligands, FMN, FMN adducts and active-site residues are colored cyan, yellow, orange and green, respectively. See <ext-link ext-link-type="uri" xlink:href="#suppinfoanchor">Supplementary Figs. S2(<italic>j</italic>)&#x02013;S2(<italic>m</italic>)</ext-link> for stereoviews and 2<italic>F</italic>
<sub>o</sub> &#x02212; <italic>F</italic>
<sub>c</sub> difference electron-density maps.</p></caption><graphic xlink:href="d-75-00918-fig4a"/><graphic xlink:href="d-75-00918-fig4b"/></fig><fig id="fig5" orientation="portrait" position="float"><label>Figure 5</label><caption><p>The proposed mechanisms of oxidative decarboxylation catalyzed by the Y128F mutant.</p></caption><graphic xlink:href="d-75-00918-fig5"/></fig><table-wrap-group id="table1" orientation="portrait" position="float"><label>Table 1</label><caption><title>Data-collection and refinement statistics for Hmo and its Y128F, Y128C and R163L mutants</title></caption><table-wrap orientation="portrait" id="d35e1963" position="anchor"><caption><p>Values in parentheses are for the highest resolution shell. SMA, (<italic>S</italic>)-mandelate; BF, benzoylformate; FMN, riboflavin mononucleotide; 5DAFMN, 5-&#x000ad;deazariboflavin mononucleotide; PPY, phenylpyruvate; MA_FMN, malonyl&#x02013;FMN; MAAD_FMN, mandelamide&#x02013;FMN.</p></caption><table frame="hsides" rules="groups"><thead valign="bottom"><tr><th style="border-bottom:1px solid black;" rowspan="1" colspan="1" align="left" valign="bottom">&#x000a0;</th><th style="border-bottom:1px solid black;" rowspan="1" colspan="1" align="left" valign="bottom">Hmo</th><th style="border-bottom:1px solid black;" rowspan="1" colspan="1" align="left" valign="bottom">Hmo&#x02013;SMA</th><th style="border-bottom:1px solid black;" rowspan="1" colspan="1" align="left" valign="bottom">Hmo&#x02013;BF</th><th style="border-bottom:1px solid black;" rowspan="1" colspan="1" align="left" valign="bottom">Y128F</th><th style="border-bottom:1px solid black;" rowspan="1" colspan="1" align="left" valign="bottom">Y128F&#x02013;SMA</th><th style="border-bottom:1px solid black;" rowspan="1" colspan="1" align="left" valign="bottom">Y128F&#x02013;BF</th><th style="border-bottom:1px solid black;" rowspan="1" colspan="1" align="left" valign="bottom">Y128F&#x02013;5DAFMN</th><th style="border-bottom:1px solid black;" rowspan="1" colspan="1" align="left" valign="bottom">Y128F&#x02013;5DAFMN&#x02013;BA</th></tr></thead><tbody valign="top"><tr><td rowspan="1" colspan="1" align="left" valign="top">PDB code</td><td rowspan="1" colspan="1" align="left" valign="top">
<ext-link ext-link-type="uri" xlink:href="https://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&#x00026;pdbId=5zzp">5zzp</ext-link>
</td><td rowspan="1" colspan="1" align="left" valign="top">
<ext-link ext-link-type="uri" xlink:href="https://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&#x00026;pdbId=5zzr">5zzr</ext-link>
</td><td rowspan="1" colspan="1" align="left" valign="top">
<ext-link ext-link-type="uri" xlink:href="https://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&#x00026;pdbId=6a08">6a08</ext-link>
</td><td rowspan="1" colspan="1" align="left" valign="top">
<ext-link ext-link-type="uri" xlink:href="https://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&#x00026;pdbId=6a13">6a13</ext-link>
</td><td rowspan="1" colspan="1" align="left" valign="top">
<ext-link ext-link-type="uri" xlink:href="https://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&#x00026;pdbId=6a0v">6a0v</ext-link>
</td><td rowspan="1" colspan="1" align="left" valign="top">
<ext-link ext-link-type="uri" xlink:href="https://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&#x00026;pdbId=6a19">6a19</ext-link>
</td><td rowspan="1" colspan="1" align="left" valign="top">
<ext-link ext-link-type="uri" xlink:href="https://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&#x00026;pdbId=6a1h">6a1h</ext-link>
</td><td rowspan="1" colspan="1" align="left" valign="top">
<ext-link ext-link-type="uri" xlink:href="https://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&#x00026;pdbId=6a1l">6a1l</ext-link>
</td></tr><tr><td rowspan="1" colspan="9" align="left" valign="top">Data collection</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;Wavelength (&#x000c5;)</td><td rowspan="1" colspan="1" align="left" valign="top">1.0</td><td rowspan="1" colspan="1" align="left" valign="top">1.0</td><td rowspan="1" colspan="1" align="left" valign="top">1.0</td><td rowspan="1" colspan="1" align="left" valign="top">1.0</td><td rowspan="1" colspan="1" align="left" valign="top">1.0</td><td rowspan="1" colspan="1" align="left" valign="top">1.0</td><td rowspan="1" colspan="1" align="left" valign="top">1.0</td><td rowspan="1" colspan="1" align="left" valign="top">1.0</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;Space group</td><td rowspan="1" colspan="1" align="left" valign="top">
<italic>I</italic>422</td><td rowspan="1" colspan="1" align="left" valign="top">
<italic>I</italic>422</td><td rowspan="1" colspan="1" align="left" valign="top">
<italic>I</italic>422</td><td rowspan="1" colspan="1" align="left" valign="top">
<italic>I</italic>422</td><td rowspan="1" colspan="1" align="left" valign="top">
<italic>I</italic>422</td><td rowspan="1" colspan="1" align="left" valign="top">
<italic>I</italic>422</td><td rowspan="1" colspan="1" align="left" valign="top">
<italic>I</italic>422</td><td rowspan="1" colspan="1" align="left" valign="top">
<italic>I</italic>422</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;
<italic>a</italic>, <italic>b</italic>, <italic>c</italic> (&#x000c5;)</td><td rowspan="1" colspan="1" align="left" valign="top">137.9, 137.9, 112.3</td><td rowspan="1" colspan="1" align="left" valign="top">137.7, 137.7, 111.6</td><td rowspan="1" colspan="1" align="left" valign="top">137.9, 137.9, 111.8</td><td rowspan="1" colspan="1" align="left" valign="top">137.5, 137.5, 112.0</td><td rowspan="1" colspan="1" align="left" valign="top">137.8, 137.8, 111.8</td><td rowspan="1" colspan="1" align="left" valign="top">137.9, 137.9, 112.3</td><td rowspan="1" colspan="1" align="left" valign="top">137.4, 137.4, 112.4</td><td rowspan="1" colspan="1" align="left" valign="top">137.7, 137.7, 111.6</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;&#x003b1;, &#x003b2;, &#x003b3; (&#x000b0;)</td><td rowspan="1" colspan="1" align="left" valign="top">90, 90, 90</td><td rowspan="1" colspan="1" align="left" valign="top">90, 90, 90</td><td rowspan="1" colspan="1" align="left" valign="top">90, 90, 90</td><td rowspan="1" colspan="1" align="left" valign="top">90, 90, 90</td><td rowspan="1" colspan="1" align="left" valign="top">90, 90, 90</td><td rowspan="1" colspan="1" align="left" valign="top">90, 90, 90</td><td rowspan="1" colspan="1" align="left" valign="top">90, 90, 90</td><td rowspan="1" colspan="1" align="left" valign="top">90, 90, 90</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;Resolution range (&#x000c5;)</td><td rowspan="1" colspan="1" align="left" valign="top">30&#x02013;1.39 (1.44&#x02013;1.39)</td><td rowspan="1" colspan="1" align="left" valign="top">30&#x02013;1.31 (1.36&#x02013;1.31)</td><td rowspan="1" colspan="1" align="left" valign="top">30&#x02013;1.55 (1.61&#x02013;1.55)</td><td rowspan="1" colspan="1" align="left" valign="top">30&#x02013;1.70 (1.76&#x02013;1.70)</td><td rowspan="1" colspan="1" align="left" valign="top">30&#x02013;1.39 (1.44&#x02013;1.39)</td><td rowspan="1" colspan="1" align="left" valign="top">30&#x02013;1.55 (1.61&#x02013;1.55)</td><td rowspan="1" colspan="1" align="left" valign="top">30&#x02013;1.36 (1.41&#x02013;1.36)</td><td rowspan="1" colspan="1" align="left" valign="top">30&#x02013;1.40 (1.45&#x02013;1.40)</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;
<italic>R</italic>
<sub>merge</sub>
<xref ref-type="table-fn" rid="tfn1">&#x02020;</xref> (%)</td><td rowspan="1" colspan="1" align="left" valign="top">3.7 (73.0)</td><td rowspan="1" colspan="1" align="left" valign="top">3.7 (67.0)</td><td rowspan="1" colspan="1" align="left" valign="top">4.0 (79.0)</td><td rowspan="1" colspan="1" align="left" valign="top">3.5 (69.2)</td><td rowspan="1" colspan="1" align="left" valign="top">4.3 (73.1)</td><td rowspan="1" colspan="1" align="left" valign="top">3.6 (75.0)</td><td rowspan="1" colspan="1" align="left" valign="top">2.8 (62.0)</td><td rowspan="1" colspan="1" align="left" valign="top">4.2 (81.0)</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;&#x02329;<italic>I</italic>/&#x003c3;(<italic>I</italic>)&#x0232a;</td><td rowspan="1" colspan="1" align="left" valign="top">36.1 (2.4)</td><td rowspan="1" colspan="1" align="left" valign="top">34.5 (2.3)</td><td rowspan="1" colspan="1" align="left" valign="top">43.1 (2.9)</td><td rowspan="1" colspan="1" align="left" valign="top">41.3 (3.1)</td><td rowspan="1" colspan="1" align="left" valign="top">41.0 (2.9)</td><td rowspan="1" colspan="1" align="left" valign="top">32.9 (2.7)</td><td rowspan="1" colspan="1" align="left" valign="top">41.2 (3.4)</td><td rowspan="1" colspan="1" align="left" valign="top">29.6 (2.4)</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;Completeness (%)</td><td rowspan="1" colspan="1" align="left" valign="top">99.9 (100.0)</td><td rowspan="1" colspan="1" align="left" valign="top">99.0 (100.0)</td><td rowspan="1" colspan="1" align="left" valign="top">100.0 (100.0)</td><td rowspan="1" colspan="1" align="left" valign="top">100.0 (100.0)</td><td rowspan="1" colspan="1" align="left" valign="top">100.0 (100.0)</td><td rowspan="1" colspan="1" align="left" valign="top">99.9 (100.0)</td><td rowspan="1" colspan="1" align="left" valign="top">99.9 (100.0)</td><td rowspan="1" colspan="1" align="left" valign="top">100.0 (100.0)</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;Multiplicity</td><td rowspan="1" colspan="1" align="left" valign="top">9.4 (9.4)</td><td rowspan="1" colspan="1" align="left" valign="top">9.8 (9.5)</td><td rowspan="1" colspan="1" align="left" valign="top">12.8 (11.2)</td><td rowspan="1" colspan="1" align="left" valign="top">11.2 (11.1)</td><td rowspan="1" colspan="1" align="left" valign="top">12.2 (12.0)</td><td rowspan="1" colspan="1" align="left" valign="top">9.6 (9.2)</td><td rowspan="1" colspan="1" align="left" valign="top">9.7 (9.4)</td><td rowspan="1" colspan="1" align="left" valign="top">10.5 (10.4)</td></tr><tr><td rowspan="1" colspan="9" align="left" valign="top">Refinement</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;Resolution range (&#x000c5;)</td><td rowspan="1" colspan="1" align="left" valign="top">30&#x02013;1.39 (1.44&#x02013;1.39)</td><td rowspan="1" colspan="1" align="left" valign="top">30&#x02013;1.31 (1.36&#x02013;1.31)</td><td rowspan="1" colspan="1" align="left" valign="top">30&#x02013;1.55 (1.61&#x02013;1.55)</td><td rowspan="1" colspan="1" align="left" valign="top">30&#x02013;1.70 (1.76&#x02013;1.70)</td><td rowspan="1" colspan="1" align="left" valign="top">30&#x02013;1.39 (1.44&#x02013;1.39)</td><td rowspan="1" colspan="1" align="left" valign="top">30&#x02013;1.55 (1.61&#x02013;1.55)</td><td rowspan="1" colspan="1" align="left" valign="top">30&#x02013;1.36 (1.41&#x02013;1.36)</td><td rowspan="1" colspan="1" align="left" valign="top">30&#x02013;1.40 (1.45&#x02013;1.40)</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;
<italic>R</italic>
<sub>work</sub>
<xref ref-type="table-fn" rid="tfn2">&#x02021;</xref> (%)</td><td rowspan="1" colspan="1" align="left" valign="top">17.0 (28.0)</td><td rowspan="1" colspan="1" align="left" valign="top">16.6 (22.9)</td><td rowspan="1" colspan="1" align="left" valign="top">16.9 (22.0)</td><td rowspan="1" colspan="1" align="left" valign="top">17.8 (24.2)</td><td rowspan="1" colspan="1" align="left" valign="top">16.7 (22.9)</td><td rowspan="1" colspan="1" align="left" valign="top">15.7 (24.4)</td><td rowspan="1" colspan="1" align="left" valign="top">16.8 (23.0)</td><td rowspan="1" colspan="1" align="left" valign="top">17.5 (28.0)</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;
<italic>R</italic>
<sub>free</sub>
<xref ref-type="table-fn" rid="tfn3">&#x000a7;</xref> (%)</td><td rowspan="1" colspan="1" align="left" valign="top">18.3 (30.0)</td><td rowspan="1" colspan="1" align="left" valign="top">17.7 (22.3)</td><td rowspan="1" colspan="1" align="left" valign="top">17.9 (20.1)</td><td rowspan="1" colspan="1" align="left" valign="top">20.0 (26.2)</td><td rowspan="1" colspan="1" align="left" valign="top">18.4 (23.1)</td><td rowspan="1" colspan="1" align="left" valign="top">17.3 (26.6)</td><td rowspan="1" colspan="1" align="left" valign="top">18.1 (26.0)</td><td rowspan="1" colspan="1" align="left" valign="top">18.6 (30.1)</td></tr><tr><td rowspan="1" colspan="9" align="left" valign="top">&#x02003;R.m.s. deviations</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;&#x02003;Bond lengths (&#x000c5;)</td><td rowspan="1" colspan="1" align="left" valign="top">0.010</td><td rowspan="1" colspan="1" align="left" valign="top">0.009</td><td rowspan="1" colspan="1" align="left" valign="top">0.008</td><td rowspan="1" colspan="1" align="left" valign="top">0.018</td><td rowspan="1" colspan="1" align="left" valign="top">0.008</td><td rowspan="1" colspan="1" align="left" valign="top">0.009</td><td rowspan="1" colspan="1" align="left" valign="top">0.017</td><td rowspan="1" colspan="1" align="left" valign="top">0.006</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;&#x02003;Bond angles (&#x000b0;)</td><td rowspan="1" colspan="1" align="left" valign="top">1.41</td><td rowspan="1" colspan="1" align="left" valign="top">1.41</td><td rowspan="1" colspan="1" align="left" valign="top">1.26</td><td rowspan="1" colspan="1" align="left" valign="top">1.490</td><td rowspan="1" colspan="1" align="left" valign="top">1.3361</td><td rowspan="1" colspan="1" align="left" valign="top">1.460</td><td rowspan="1" colspan="1" align="left" valign="top">1.421</td><td rowspan="1" colspan="1" align="left" valign="top">0.982</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;No. of reflections</td><td rowspan="1" colspan="1" align="left" valign="top">100548</td><td rowspan="1" colspan="1" align="left" valign="top">112497</td><td rowspan="1" colspan="1" align="left" valign="top">75720</td><td rowspan="1" colspan="1" align="left" valign="top">58599</td><td rowspan="1" colspan="1" align="left" valign="top">98014</td><td rowspan="1" colspan="1" align="left" valign="top">74156</td><td rowspan="1" colspan="1" align="left" valign="top">114232</td><td rowspan="1" colspan="1" align="left" valign="top">104841</td></tr><tr><td rowspan="1" colspan="9" align="left" valign="top">&#x02003;No. of atoms</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;&#x02003;Protein</td><td rowspan="1" colspan="1" align="left" valign="top">2785</td><td rowspan="1" colspan="1" align="left" valign="top">2622</td><td rowspan="1" colspan="1" align="left" valign="top">2684</td><td rowspan="1" colspan="1" align="left" valign="top">2510</td><td rowspan="1" colspan="1" align="left" valign="top">2636</td><td rowspan="1" colspan="1" align="left" valign="top">2703</td><td rowspan="1" colspan="1" align="left" valign="top">2548</td><td rowspan="1" colspan="1" align="left" valign="top">2574</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;&#x02003;Ligand/ion</td><td rowspan="1" colspan="1" align="left" valign="top">31</td><td rowspan="1" colspan="1" align="left" valign="top">53</td><td rowspan="1" colspan="1" align="left" valign="top">65</td><td rowspan="1" colspan="1" align="left" valign="top">31</td><td rowspan="1" colspan="1" align="left" valign="top">53</td><td rowspan="1" colspan="1" align="left" valign="top">53</td><td rowspan="1" colspan="1" align="left" valign="top">31</td><td rowspan="1" colspan="1" align="left" valign="top">55</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;&#x02003;Water</td><td rowspan="1" colspan="1" align="left" valign="top">403</td><td rowspan="1" colspan="1" align="left" valign="top">402</td><td rowspan="1" colspan="1" align="left" valign="top">329</td><td rowspan="1" colspan="1" align="left" valign="top">316</td><td rowspan="1" colspan="1" align="left" valign="top">400</td><td rowspan="1" colspan="1" align="left" valign="top">400</td><td rowspan="1" colspan="1" align="left" valign="top">440</td><td rowspan="1" colspan="1" align="left" valign="top">335</td></tr><tr><td rowspan="1" colspan="9" align="left" valign="top">&#x02003;
<italic>B</italic> factors (&#x000c5;<sup>2</sup>)</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;&#x02003;Protein</td><td rowspan="1" colspan="1" align="left" valign="top">18.2</td><td rowspan="1" colspan="1" align="left" valign="top">19.7</td><td rowspan="1" colspan="1" align="left" valign="top">19.1</td><td rowspan="1" colspan="1" align="left" valign="top">18.6</td><td rowspan="1" colspan="1" align="left" valign="top">16.9</td><td rowspan="1" colspan="1" align="left" valign="top">21.9</td><td rowspan="1" colspan="1" align="left" valign="top">18.4</td><td rowspan="1" colspan="1" align="left" valign="top">20.5</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;&#x02003;Ligand/ion</td><td rowspan="1" colspan="1" align="left" valign="top">10.7</td><td rowspan="1" colspan="1" align="left" valign="top">19.0</td><td rowspan="1" colspan="1" align="left" valign="top">20.6</td><td rowspan="1" colspan="1" align="left" valign="top">10.8</td><td rowspan="1" colspan="1" align="left" valign="top">17.8</td><td rowspan="1" colspan="1" align="left" valign="top">29.4</td><td rowspan="1" colspan="1" align="left" valign="top">12.1</td><td rowspan="1" colspan="1" align="left" valign="top">17.1</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;&#x02003;Water</td><td rowspan="1" colspan="1" align="left" valign="top">32.4</td><td rowspan="1" colspan="1" align="left" valign="top">33.9</td><td rowspan="1" colspan="1" align="left" valign="top">31.7</td><td rowspan="1" colspan="1" align="left" valign="top">32.1</td><td rowspan="1" colspan="1" align="left" valign="top">32.2</td><td rowspan="1" colspan="1" align="left" valign="top">37.3</td><td rowspan="1" colspan="1" align="left" valign="top">34.9</td><td rowspan="1" colspan="1" align="left" valign="top">26.6</td></tr></tbody></table></table-wrap><table-wrap orientation="portrait" id="d35e2523" position="anchor"><table frame="hsides" rules="groups"><thead valign="bottom"><tr><th style="border-bottom:1px solid black;" rowspan="1" colspan="1" align="left" valign="bottom">&#x000a0;</th><th style="border-bottom:1px solid black;" rowspan="1" colspan="1" align="left" valign="bottom">Y128F&#x02013;5DAFMN&#x02013;BF</th><th style="border-bottom:1px solid black;" rowspan="1" colspan="1" align="left" valign="bottom">Y128F&#x02013;5DAFMN&#x02013;PPY</th><th style="border-bottom:1px solid black;" rowspan="1" colspan="1" align="left" valign="bottom">Y128F&#x02013;PPY&#x02013;FMN</th><th style="border-bottom:1px solid black;" rowspan="1" colspan="1" align="left" valign="bottom">Y128F&#x02013;MA_FMN</th><th style="border-bottom:1px solid black;" rowspan="1" colspan="1" align="left" valign="bottom">Y128F&#x02013;BF&#x02013;FMN</th><th style="border-bottom:1px solid black;" rowspan="1" colspan="1" align="left" valign="bottom">Y128C&#x02013;BF</th><th style="border-bottom:1px solid black;" rowspan="1" colspan="1" align="left" valign="bottom">R163L&#x02013;MAAD_FMN</th></tr></thead><tbody valign="top"><tr><td rowspan="1" colspan="1" align="left" valign="top">PDB code</td><td rowspan="1" colspan="1" align="left" valign="top">
<ext-link ext-link-type="uri" xlink:href="https://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&#x00026;pdbId=6a1m">6a1m</ext-link>
</td><td rowspan="1" colspan="1" align="left" valign="top">
<ext-link ext-link-type="uri" xlink:href="https://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&#x00026;pdbId=6a1p">6a1p</ext-link>
</td><td rowspan="1" colspan="1" align="left" valign="top">
<ext-link ext-link-type="uri" xlink:href="https://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&#x00026;pdbId=6a1r">6a1r</ext-link>
</td><td rowspan="1" colspan="1" align="left" valign="top">
<ext-link ext-link-type="uri" xlink:href="https://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&#x00026;pdbId=6a21">6a21</ext-link>
</td><td rowspan="1" colspan="1" align="left" valign="top">
<ext-link ext-link-type="uri" xlink:href="https://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&#x00026;pdbId=6a23">6a23</ext-link>
</td><td rowspan="1" colspan="1" align="left" valign="top">
<ext-link ext-link-type="uri" xlink:href="https://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&#x00026;pdbId=5zzz">5zzz</ext-link>
</td><td rowspan="1" colspan="1" align="left" valign="top">
<ext-link ext-link-type="uri" xlink:href="https://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&#x00026;pdbId=6a3t">6a3t</ext-link>
</td></tr><tr><td rowspan="1" colspan="8" align="left" valign="top">Data collection</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;Wavelength (&#x000c5;)</td><td rowspan="1" colspan="1" align="left" valign="top">1.0</td><td rowspan="1" colspan="1" align="left" valign="top">1.0</td><td rowspan="1" colspan="1" align="left" valign="top">1.0</td><td rowspan="1" colspan="1" align="left" valign="top">1.0</td><td rowspan="1" colspan="1" align="left" valign="top">1.0</td><td rowspan="1" colspan="1" align="left" valign="top">1.0</td><td rowspan="1" colspan="1" align="left" valign="top">1.0</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;Space group</td><td rowspan="1" colspan="1" align="left" valign="top">
<italic>I</italic>422</td><td rowspan="1" colspan="1" align="left" valign="top">
<italic><italic>I</italic>422</italic>
</td><td rowspan="1" colspan="1" align="left" valign="top">
<italic>I</italic>422</td><td rowspan="1" colspan="1" align="left" valign="top">
<italic>I</italic>422</td><td rowspan="1" colspan="1" align="left" valign="top">
<italic>I</italic>422</td><td rowspan="1" colspan="1" align="left" valign="top">
<italic>I</italic>422</td><td rowspan="1" colspan="1" align="left" valign="top">
<italic>I</italic>422</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;
<italic>a</italic>, <italic>b</italic>, <italic>c</italic> (&#x000c5;)</td><td rowspan="1" colspan="1" align="left" valign="top">137.9, 137.9, 111.2</td><td rowspan="1" colspan="1" align="left" valign="top">138.0, 138.0, 111.1</td><td rowspan="1" colspan="1" align="left" valign="top">138.1, 138.1, 112.1</td><td rowspan="1" colspan="1" align="left" valign="top">137.6, 137.6, 112.1</td><td rowspan="1" colspan="1" align="left" valign="top">137.8, 137.8, 111.8</td><td rowspan="1" colspan="1" align="left" valign="top">138.2, 138.2, 112.1</td><td rowspan="1" colspan="1" align="left" valign="top">137.4, 137.4, 111.7</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;&#x003b1;, &#x003b2;, &#x003b3; (&#x000b0;)</td><td rowspan="1" colspan="1" align="left" valign="top">90, 90, 90</td><td rowspan="1" colspan="1" align="left" valign="top">90, 90, 90</td><td rowspan="1" colspan="1" align="left" valign="top">90, 90, 90</td><td rowspan="1" colspan="1" align="left" valign="top">90, 90, 90</td><td rowspan="1" colspan="1" align="left" valign="top">90, 90, 90</td><td rowspan="1" colspan="1" align="left" valign="top">90, 90, 90</td><td rowspan="1" colspan="1" align="left" valign="top">90, 90, 90</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;Resolution range (&#x000c5;)</td><td rowspan="1" colspan="1" align="left" valign="top">30&#x02013;1.55 (1.61&#x02013;1.55)</td><td rowspan="1" colspan="1" align="left" valign="top">30&#x02013;1.51 (1.56&#x02013;1.51)</td><td rowspan="1" colspan="1" align="left" valign="top">30&#x02013;1.65 (1.71&#x02013;1.65)</td><td rowspan="1" colspan="1" align="left" valign="top">30&#x02013;1.50 (1.55&#x02013;1.50)</td><td rowspan="1" colspan="1" align="left" valign="top">30&#x02013;1.65 (1.71&#x02013;1.65)</td><td rowspan="1" colspan="1" align="left" valign="top">30&#x02013;1.45 (1.50&#x02013;1.45)</td><td rowspan="1" colspan="1" align="left" valign="top">30&#x02013;2.51 (2.60&#x02013;2.51)</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;
<italic>R</italic>
<sub>merge</sub>
<xref ref-type="table-fn" rid="tfn1">&#x02020;</xref> (%)</td><td rowspan="1" colspan="1" align="left" valign="top">3.9 (57.0)</td><td rowspan="1" colspan="1" align="left" valign="top">3.6 (72.1)</td><td rowspan="1" colspan="1" align="left" valign="top">4.4 (73.0)</td><td rowspan="1" colspan="1" align="left" valign="top">3.2 (64.3)</td><td rowspan="1" colspan="1" align="left" valign="top">3.8 (70.1)</td><td rowspan="1" colspan="1" align="left" valign="top">4.4 (69.2)</td><td rowspan="1" colspan="1" align="left" valign="top">10.1 (66.0)</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;&#x02329;<italic>I</italic>/&#x003c3;(<italic>I</italic>)&#x0232a;</td><td rowspan="1" colspan="1" align="left" valign="top">40.8 (2.4)</td><td rowspan="1" colspan="1" align="left" valign="top">30.4 (2.3)</td><td rowspan="1" colspan="1" align="left" valign="top">36.8 (3.16)</td><td rowspan="1" colspan="1" align="left" valign="top">40.0 (3.2)</td><td rowspan="1" colspan="1" align="left" valign="top">28.4 (2.0)</td><td rowspan="1" colspan="1" align="left" valign="top">33.5 (2.6)</td><td rowspan="1" colspan="1" align="left" valign="top">15.2 (2.4)</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;Completeness (%)</td><td rowspan="1" colspan="1" align="left" valign="top">99.7 (97.2)</td><td rowspan="1" colspan="1" align="left" valign="top">99.8 (98.3)</td><td rowspan="1" colspan="1" align="left" valign="top">100.0 (100.0)</td><td rowspan="1" colspan="1" align="left" valign="top">99.9 (100.0)</td><td rowspan="1" colspan="1" align="left" valign="top">99.3 (100.0)</td><td rowspan="1" colspan="1" align="left" valign="top">99.9 (100.0)</td><td rowspan="1" colspan="1" align="left" valign="top">99.9 (100.0)</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;Multiplicity</td><td rowspan="1" colspan="1" align="left" valign="top">11.4 (9.1)</td><td rowspan="1" colspan="1" align="left" valign="top">9.4 (7.7)</td><td rowspan="1" colspan="1" align="left" valign="top">12.2 (12.1)</td><td rowspan="1" colspan="1" align="left" valign="top">9.8 (9.8)</td><td rowspan="1" colspan="1" align="left" valign="top">9.1 (8.8)</td><td rowspan="1" colspan="1" align="left" valign="top">9.9 (9.9)</td><td rowspan="1" colspan="1" align="left" valign="top">9.5 (9.3)</td></tr><tr><td rowspan="1" colspan="6" align="left" valign="top">Refinement</td><td rowspan="1" colspan="1" align="left" valign="top">&#x000a0;</td><td rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;Resolution range (&#x000c5;)</td><td rowspan="1" colspan="1" align="left" valign="top">30&#x02013;1.55 (1.61&#x02013;1.55)</td><td rowspan="1" colspan="1" align="left" valign="top">30&#x02013;1.51 (1.56&#x02013;1.51)</td><td rowspan="1" colspan="1" align="left" valign="top">30&#x02013;1.65 (1.71&#x02013;1.65)</td><td rowspan="1" colspan="1" align="left" valign="top">30&#x02013;1.50 (1.55&#x02013;1.50)</td><td rowspan="1" colspan="1" align="left" valign="top">30&#x02013;1.65 (1.71&#x02013;1.65)</td><td rowspan="1" colspan="1" align="left" valign="top">30&#x02013;1.45 (1.50&#x02013;1.45)</td><td rowspan="1" colspan="1" align="left" valign="top">30&#x02013;2.51 (2.60&#x02013;2.51)</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;
<italic>R</italic>
<sub>work</sub>
<xref ref-type="table-fn" rid="tfn2">&#x02021;</xref> (%)</td><td rowspan="1" colspan="1" align="left" valign="top">17.8 (25.7)</td><td rowspan="1" colspan="1" align="left" valign="top">17.0 (26.1)</td><td rowspan="1" colspan="1" align="left" valign="top">16.3 (20.6)</td><td rowspan="1" colspan="1" align="left" valign="top">16.7 (22.4)</td><td rowspan="1" colspan="1" align="left" valign="top">17.3 (24.1)</td><td rowspan="1" colspan="1" align="left" valign="top">17.5 (22.8)</td><td rowspan="1" colspan="1" align="left" valign="top">17.8 (21.6)</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;
<italic>R</italic>
<sub>free</sub>
<xref ref-type="table-fn" rid="tfn3">&#x000a7;</xref> (%)</td><td rowspan="1" colspan="1" align="left" valign="top">20.1 (26.5)</td><td rowspan="1" colspan="1" align="left" valign="top">19.7 (26.8)</td><td rowspan="1" colspan="1" align="left" valign="top">18.5 (22.5)</td><td rowspan="1" colspan="1" align="left" valign="top">19.0 (22.9)</td><td rowspan="1" colspan="1" align="left" valign="top">19.4 (24.9)</td><td rowspan="1" colspan="1" align="left" valign="top">19.2 (27.2)</td><td rowspan="1" colspan="1" align="left" valign="top">22.4 (29.1)</td></tr><tr><td rowspan="1" colspan="8" align="left" valign="top">&#x02003;R.m.s. deviations</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;&#x02003;Bond lengths (&#x000c5;)</td><td rowspan="1" colspan="1" align="left" valign="top">0.018</td><td rowspan="1" colspan="1" align="left" valign="top">0.015</td><td rowspan="1" colspan="1" align="left" valign="top">0.019</td><td rowspan="1" colspan="1" align="left" valign="top">0.018</td><td rowspan="1" colspan="1" align="left" valign="top">0.006</td><td rowspan="1" colspan="1" align="left" valign="top">0.010</td><td rowspan="1" colspan="1" align="left" valign="top">0.008</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;&#x02003;Bond angles (&#x000b0;)</td><td rowspan="1" colspan="1" align="left" valign="top">1.501</td><td rowspan="1" colspan="1" align="left" valign="top">1.357</td><td rowspan="1" colspan="1" align="left" valign="top">1.529</td><td rowspan="1" colspan="1" align="left" valign="top">1.557</td><td rowspan="1" colspan="1" align="left" valign="top">1.173</td><td rowspan="1" colspan="1" align="left" valign="top">1.300</td><td rowspan="1" colspan="1" align="left" valign="top">1.29</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;No. of reflections</td><td rowspan="1" colspan="1" align="left" valign="top">75042</td><td rowspan="1" colspan="1" align="left" valign="top">83439</td><td rowspan="1" colspan="1" align="left" valign="top">64602</td><td rowspan="1" colspan="1" align="left" valign="top">84212</td><td rowspan="1" colspan="1" align="left" valign="top">59812</td><td rowspan="1" colspan="1" align="left" valign="top">93717</td><td rowspan="1" colspan="1" align="left" valign="top">17837</td></tr><tr><td rowspan="1" colspan="8" align="left" valign="top">&#x02003;No. of atoms</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;&#x02003;Protein</td><td rowspan="1" colspan="1" align="left" valign="top">2485</td><td rowspan="1" colspan="1" align="left" valign="top">2539</td><td rowspan="1" colspan="1" align="left" valign="top">2586</td><td rowspan="1" colspan="1" align="left" valign="top">2626</td><td rowspan="1" colspan="1" align="left" valign="top">2606</td><td rowspan="1" colspan="1" align="left" valign="top">2481</td><td rowspan="1" colspan="1" align="left" valign="top">2496</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;&#x02003;Ligand/ion</td><td rowspan="1" colspan="1" align="left" valign="top">53</td><td rowspan="1" colspan="1" align="left" valign="top">44</td><td rowspan="1" colspan="1" align="left" valign="top">41</td><td rowspan="1" colspan="1" align="left" valign="top">37</td><td rowspan="1" colspan="1" align="left" valign="top">51</td><td rowspan="1" colspan="1" align="left" valign="top">42</td><td rowspan="1" colspan="1" align="left" valign="top">43</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;&#x02003;Water</td><td rowspan="1" colspan="1" align="left" valign="top">298</td><td rowspan="1" colspan="1" align="left" valign="top">331</td><td rowspan="1" colspan="1" align="left" valign="top">303</td><td rowspan="1" colspan="1" align="left" valign="top">375</td><td rowspan="1" colspan="1" align="left" valign="top">301</td><td rowspan="1" colspan="1" align="left" valign="top">357</td><td rowspan="1" colspan="1" align="left" valign="top">91</td></tr><tr><td rowspan="1" colspan="8" align="left" valign="top">&#x02003;
<italic>B</italic> factors (&#x000c5;<sup>2</sup>)</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;&#x02003;Protein</td><td rowspan="1" colspan="1" align="left" valign="top">19.3</td><td rowspan="1" colspan="1" align="left" valign="top">22.2</td><td rowspan="1" colspan="1" align="left" valign="top">17.9</td><td rowspan="1" colspan="1" align="left" valign="top">19.0</td><td rowspan="1" colspan="1" align="left" valign="top">19.1</td><td rowspan="1" colspan="1" align="left" valign="top">18.7</td><td rowspan="1" colspan="1" align="left" valign="top">40.29</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;&#x02003;Ligand/ion</td><td rowspan="1" colspan="1" align="left" valign="top">14.8</td><td rowspan="1" colspan="1" align="left" valign="top">18.2</td><td rowspan="1" colspan="1" align="left" valign="top">11.7</td><td rowspan="1" colspan="1" align="left" valign="top">16.7</td><td rowspan="1" colspan="1" align="left" valign="top">16.6</td><td rowspan="1" colspan="1" align="left" valign="top">20.0</td><td rowspan="1" colspan="1" align="left" valign="top">40.89</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;&#x02003;Water</td><td rowspan="1" colspan="1" align="left" valign="top">34.2</td><td rowspan="1" colspan="1" align="left" valign="top">35.2</td><td rowspan="1" colspan="1" align="left" valign="top">30.2</td><td rowspan="1" colspan="1" align="left" valign="top">33.2</td><td rowspan="1" colspan="1" align="left" valign="top">30.4</td><td rowspan="1" colspan="1" align="left" valign="top">31.6</td><td rowspan="1" colspan="1" align="left" valign="top">38.94</td></tr></tbody></table><table-wrap-foot><fn id="tfn1"><label>&#x02020;</label><p>
<italic>R</italic>
<sub>merge</sub> = <inline-formula><inline-graphic xlink:href="d-75-00918-efi1.jpg" mimetype="image" mime-subtype="gif"/></inline-formula>
<inline-formula><inline-graphic xlink:href="d-75-00918-efi2.jpg" mimetype="image" mime-subtype="gif"/></inline-formula>, where &#x02329;<italic>I</italic>(<italic>hkl</italic>)&#x0232a; is the average intensity value of the equivalent reflections.</p></fn><fn id="tfn2"><label>&#x02021;</label><p>
<italic>R</italic>
<sub>work</sub> = <inline-formula><inline-graphic xlink:href="d-75-00918-efi3.jpg" mimetype="image" mime-subtype="gif"/></inline-formula>
<inline-formula><inline-graphic xlink:href="d-75-00918-efi4.jpg" mimetype="image" mime-subtype="gif"/></inline-formula>.</p></fn><fn id="tfn3"><label>&#x000a7;</label><p>
<italic>R</italic>
<sub>free</sub> was calculated from 5% of data that were randomly excluded from refinement.</p></fn></table-wrap-foot></table-wrap></table-wrap-group></floats-group></article>